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ABSTRACT 
Ty5 is a retrotransposon in Saccharomyces cerevisiae. In wild type yeast strains, over 90% 
of Ty5 insertions occur at the telomeres or HM loci. These regions are bound in silent 
chromatin, which is analogous to heterochromatin of higher eukaryotes. Our laboratory 
previously described a targeting mutant of Ty5 that has an amino acid substitution near the 
C-terminus of integrase. Targeting to silent chromatin is reduced more than 20-fold in the 
mutant. We further defined the Ty5 targeting domain (TD) by saturation mutagenesis. All of 
the targeting mutations mapped to a stretch of six amino acids (LDSSPP). We tethered TD 
to a crippled HMR-E silencer by fusing it to the GAL4 DNA binding domain (GBD-TD). 
The GBD-TD fusion could nucleate the assembly of silent chromatin, as measured by the 
transcriptional status of an adjacent marker gene. This silencing was dependent upon the 
silent chromatin components Sir2p, Sir3p, and Sir4p. When over-expressed, GBD-TD was 
found to disrupt silencing at the telomeres. These results support our model that Ty5 target 
specificity results from a protein-protein interaction, which recruits the Ty5 pre-integration 
complex to silent chromatin. We further determined that TD interacts with Sir4p, a structural 
component of silent chromatin. This interaction between TD and Sir4p C-terminus was 
demonstrated by two-hybrid assays and in vitro affinity binding. We noticed that TD is able 
to bind Sir4p in vitro when it is expressed and purified from yeast cells but not from E. coli 
cells. In addition, protein phosphatase treatment of TD disrupts this binding. When we 
replaced the serines of TD with threonine or glutamate, TD is partially functional, and 
mutant Ty5 elements are able to target effectively. We inferred that TD is phosphorylated 
by kinases and that TD function depends on this modification. A collection of kinase 
knockout strains was used to identify the kinases that modify TD. Dunlp, the DNA damage 
checkpoint kinase, is the most likely kinase involved in Ty5 targeting and TD modification. 
This finding sheds light on how Ty5 targeting is regulated by the host and further defines the 
close relationship between Ty5 and its host. 
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CHAPTER I. GENERAL INTRODUCTION 
Transposable elements 
A gene is typically a DNA sequence, which stores a unit of genetic information and guides 
synthesis of RNA and then protein molecules. Genes are usually arranged linearly in huge 
DNA molecules called chromosomes. Most genes normally have a fixed position in a 
chromosome relative to other genes; only in rare events can they be inverted or translocated. 
However, there are certain genes or DNA sequences able to move from one position to 
another, and they are called transposable elements (TEs). 
TEs include DNA transposons and retrotransposons. A typical DNA transposon consists of a 
transposase gene flanked by inverted repeats at both ends (Fig. 1). Transposase excises the 
element from its original position and inserts it into a new site. This event leaves behind 4-
12 bp direct repeats. This well-known "cut and paste" mechanism does not typically increase 
the copy number of the element in the genome. On the contrary, a retrotransposon utilizes a 
"copy and paste" mechanism to multiply itself through transposition. Retrotransposons are 
first transcribed into mRNA. This RNA is translated to produce proteins, including a reverse 
transcriptase (RT). RT can use the retrotransposon mRNA as a template to make cDNA. 
The cDNA molecules are then inserted into a new position in the genome. 
Retrotransposable elements are divided into two big groups, the LTR (long terminal repeat) 
and non-LTR elements. An intact non-LTR element encodes one or two open reading frames 
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(ORFs) without flanking repeats (Fig. 1). An RNA Pol II promoter, fortuitously located in 
the upstream of an element, drives transcription. One of the translated proteins functions as 
both reverse transcriptase (RT) and restriction-like endonuclease (EN). This protein binds to 
the poly(A) mRNA of the element and forms a RNA-protein complex (RNP). The RNP 
then moves to the nucleus and finds a T-rich track. EN makes a nick at the tract, and the 
poly(A) end of the element mRNA pairs to a short sequence of the T-track. RT then starts 
synthesis of the cDNA from the nick using the mRNA template. The host DNA repair 
system finishes the job by linking the ends and completing synthesis of the other strand of the 
element (Kazazian and Goodier 2002). Non-LTR retrotransposons are also called LINEs, 
meaning "long interspersed nuclear elements". SINEs (short interspersed nuclear elements) 
resemble LINEs, but do not encode any genes and are transcribed by RNA Pol III. SINES 
are believed to replicate by exploiting the replication machinery of LINEs (Weiner 2002). 
LTR retrotransposons are closely related to retroviruses. They share a similar genomic 
organization (Fig. 1) and life cycle (Fig. 2). Between the LTRs are encoded proteins like RT, 
integrase (IN) and Gag. Retroviral genomes additionally encode an envelope gene (env). 
LTRs usually contain a Pol II promoter, and the whole retroelement genome is transcribed 
into a single mRNA molecule. RT and IN (and sometimes Gag) are translated into a single 
polyprotein. A retroelement-encoded protease usually cleaves the polyprotein into individual 
peptides (e.g. RT and IN). Multiple molecules of Gag form a capsid in the cytoplasm. 
Within the capsid are packaged two copies of the mRNA along with RT, IN and a host 
tRNA, which is used as a primer for reverse transcription. Retrovirus particles may leave the 
cell after Env proteins assemble on the cell surface. However, for retrotransposons, the 
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particles are trapped in the cell and reverse transcription happens within the particle in the 
cytoplasm. After the double-strand cDNA is synthesized, the particle dissembles and forms a 
pre-integration complex (PIC) near the nuclear periphery. This PIC primarily consists of the 
cDNA and multimeric IN. The PIC passes through the nuclear membrane pores or waits for 
nuclear membrane degeneration during mitosis, and then the PIC inserts the cDNA to the 
genome. 
Integrase and integration 
The integrase of retrotransposable elements and the transposase of DNA transposons are 
functionally equivalent (Haren et al. 1999). During transposition, the enzymes dimerize (or 
possibly tetramerize in the case of integrase) and join the two ends of the element DNA to 
form a synaptic complex (the PIC for example). The enzymes then catalyze two steps: first 
they nick the element DNA ends to generate free 3'OH, then they use these two 3'OH to 
attack two phosphodiester bonds on different strands of the target DNA. The two 
phosphodiester bonds are typically separated by 4-12bp. The first step of the reaction is 
called end-processing, and the second step is called strand transfer or joining. The donor 
DNA of the retroelement is the cDNA synthesized by RT. Integrase works like an 
endonuclease to cut off two nucleotides at the 3' ends of the LTRs, leaving a 2-nucleotide 5' 
overhang. The 3'OH then serves as nucleophile for the next step of DNA strand transfer in 
which the 3' end of each strand of the donor DNA is linked to the 5' end of each strand of the 
recipient DNA. In the final step, the host DNA repair system finishes the integration reaction 
by filling in the gap and ligating the 5'-end of the donor with the 3'-end of the recipient (Fig. 
3). 
The catalytic (core) domain of integrase is conserved structurally and functionally among all 
retroelements and with the transposases of most DNA transposons (Capy et al. 1996). 
Integrase and transposase contain a DDE amino acid signature (the second aspartate is 
typically separated by 35 aa from the glutamate; Fig. 4). In the known crystal structures of 
integrase catalytic domains, these 3 aa residues are close together within the catalytic pocket 
(Haren et al. 1999). Furthermore, in the recently resolved crystal structure of a Tn5 
transposase-DNA complex, the DNA ends, which mimic the digested retroelement ends, are 
very close to the DDE residues (Rice and Baker 2001). This structural data clearly indicates 
a core role for these residues in catalysis. Divalent metal ions also have been shown to be 
captured by these acidic amino acids. Although only one ion is shown in the crystal 
structures, a reaction model has been proposed that utilizes two magnesium ions in the 
catalytic pocket. This model is based on many other enzymes that catalyze 
phosphoryltransfer reactions (Haren et al. 1999). 
During transposition, both ends of an element should be processed simultaneously in order to 
insert the element into a single target site. To accomplish this, dimerization of the catalytic 
domain and synapsis of the donor DNA ends are necessary. In support of synapsis, deletions 
placed in the end of the 3' LTR affect processing of both ends of the cDNA (Murphy and 
Goff 1992). In the Tn5 crystal structure, the contacts between the DNA and protein and 
between the two subunits are extensive and interwoven. Therefore, a concerted strategy has 
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been proposed for both LTR elements and DNA transposons in which synapsis is a 
prerequisite condition (Rice and Baker 2001). Although the pairing of catalytic domains 
seems the only solution here, data regarding dimerization of integrase is contradictory. In 
vitro integration studies, in which a mutated DDE motif is complemented by N-terminal or 
C-terminal truncated IN (see below), did not support the dimer model (Engelman et al. 1993; 
van Gent et al. 1993). Thus, a tetramer or even octomer was suggested. 
There is not any structural data yet to help describe how the strand-transfer step happens. 
Nevertheless, it is believed that the same complex nonspecifically binds to the target DNA 
and executes the second reaction in the same pair of active sites. Indeed, the structure of the 
Tn5 protein-DNA complex has revealed a highly positively charged groove between the 
active sites, which is big enough to fit the target DNA (Rice and Baker 2001). 
Besides the core domain, retroelement integrases have two other conserved domains at the N-
and C-termini. These domains are not conserved in transposases, even though transposases 
also have two domains in the corresponding positions (Fig. 4). The N-terminal domain of IN 
is a HHCC zinc finger. This domain is suggested to play an important role in LTR-end 
recognition and in synapsis, because mutations in any of the residues in the HHCC motif of 
HIV nearly or completely abolish end-processing and joining reactions (Engelman and 
Craigie 1992; Engelman et al. 1995). The C-terminal domain is about 40 amino acids after 
the catalytic domain. This domain is the least conserved among retroelement integrases. In 
HIV, the C-terminus contains a SH3 fold motif and is suggested to function in nonspecific 
binding to DNA (Brown 1997). Deletion mutations also showed that the C-terminus is 
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needed for multimerization. In contrast to the short C-terminal domain of the viral INs, the 
retrotransposons frequently have much longer IN C-termini (e.g. Tyl and Ty5 in Fig. 4). 
The functional study of the retrotransposon Ty5 IN C-terminus is part of my thesis work. 
Ty elements and targeted integration 
Tyl-Ty5 are 5 families of retrotransposons in the yeast Saccharomyces. These elements 
belong to two lineages of retroelements. Ty3 is in the Ty3/gypsy group, in which reverse 
transcriptase is encoded upstream of the integrase. Others are in the Tyl/copia group, in 
which RT and IN are encoded in the opposite way (Fig. 1). Because S. cerevisiae is an ideal 
model organism for molecular biology, Tyl, Ty3, and Ty5, as representatives of diverse 
retrotransposons, are under extensive study. They are especially of interest because of their 
integration target specificity. 
The idea for retroelement integration preference originally came from some observations 
with retroviruses. All retroviruses show preferences for some target sites over others. 
Certain individual sites have been observed with >1000 fold more insertions than other sites 
within a few Kb stretch of DNA (Shih et al. 1988; Kitamura et al. 1992; Withers-Ward et al. 
1994). However, there is no significant evidence indicating any consensus DNA for the 
retroviral targets. In vitro integration of MLV and HIV showed preference of nucleosomes 
to naked DNA (Pryciak et al. 1992a; Pryciak et al. 1992b; Pryciak and Varmus 1992). The 
pattern of integration into nucleosomal DNA sites indicated that the sites of the major groove 
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facing outward were favored (Pruss et al. 1994). The data suggest the accessibility of the 
target DNA determines local target specificity. Supporting this hypothesis, proteins bound to 
DNA (obviously in a different way than histones in a nucleosome) block integration (Pryciak 
and Varmus 1992; Bushman 1994). 
Not until the availability of the human genome sequence, has a study of the genome-wide 
distribution of HIV integration sites been possible. This study indicates that more than 60% 
of the insertions are associateed with RNA Pol II-transcribed genes, and there was a clear 
preference for genes that are actively transcribed. Additionally, regional hotspots for 
integration were found that are enriched in active genes (Schroder et al. 2002). Although 
there is not a simple explanation for the data, it is suggested that the structure and 
organization of the human genome, which affects the accessibility of the virus PIC, should 
play an important role. 
The Ty retrotransposons have a much stronger preference for choosing specific chromosomal 
regions for integration. Tyl, Ty3, and Ty5 are targeted to their preferred sites over 90% of 
the time (Kim et al. 1998). Tyl and Ty5 choose target sites within well-defined windows. 
Tyl targets are within 750 bp upstream of RNA Pol III genes, including tRNAs, U6 and 5 S 
rRNA (Devine and Boeke 1996). Ty5 preferentially inserts into silent chromatin, which can 
span several Kbs at the telomeres and silent mating loci (Zou et al. 1996). On the contrary, 
Ty3 integration sites are often restricted to within a few bases of the transcription start sites 
of RNA Pol III genes (Chalker and Sandmeyer 1992). 
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Studies with Ty3 argue against the idea that the element chooses specific DNA sequences for 
integration. RNA Pol III promoter mutations, which affect the ability of transcription factors 
to bind at positions distant from target sites, also block Ty3 integration. Therefore, a 
mechanism based on interaction between Ty3 and the Pol III transcriptional machinery is 
reasonable to explain Ty3 targeting. Pol III transcription factors TFIIIB and TFIIIC are 
involved in the targeting (Kirchner et al. 1995). More recent studies show that the Brf and 
TBP subunits of TFIIIB direct Ty3 integration in vitro (Yieh et al. 2000). TFIIIC is not 
essential for the targeting, but it directs the orientation of TFIIIB for transcription initiation 
and hence Ty3 insertion (Yieh et al. 2002). Because of the lack of an effective assay to 
identify mutations in Ty3 that affect targeting, it is not yet known which Ty3-encoded factors 
are responsible for interactions with the transcription factors. 
It has been suggested that the Pol III transcription machinery is also involved in Tyl 
targeting, since promoter mutations have similar negative effects on Tyl integration (Devine 
and Boeke 1996). However, because Tyl integration occurs within a "window" instead of at 
specific sites, this implies that the transcription factors themselves do not directly guide 
integration. In support of this, in vitro experiments with purified transcription components 
failed to restore targeting (Devine and Boeke, unpublished data). Some other feature of 
chromatin within the window, which could be certain chromatin binding proteins or histone 
modifications, is most likely involved. Recently, many reports support that chromatin 
domains are extensively marked by different combinations of histone modifications (called 
histone codes), so this should not be ignored when considering Tyl targeting. 
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Heterochromatin and silencing 
An overview of silent chromatin is provided before talking about how Ty5 selects these 
chromatin domains during integration. 
Silent chromatin is defined as chromatin domains that are not conducive to transcription. 
Silent chromatin is referred to as heterochromatin in higher organisms. In Saccharomyces 
cerevisiae, silent chromatin includes the telomeric regions, the silent mating loci HMR and 
HML, and the rDNA repeats (Laurenson and Rine 1992; Huang 2002). 
The silent mating loci. The silent mating loci are among the best-studied domains of silent 
chromatin. There are three mating loci located on chromosome III. The non-silent locus, 
MAT, expresses genes that determine the mating type of the cell (either a or a). The HMR 
and HML loci also encode genes that determine a (HMR) and a (HML) mating type, but they 
are not transcribed. Mating type can switch when the HM locus that has the opposite genes 
to MAT acts as a donor for the gene conversion of MAT by homologous recombination. 
Silencing is regulated at the HM loci by four Sir (silent information regulator) proteins. 
Sir2p, Sir3p, and Sir4p are essential components of silent chromatin. Strains with mutations 
in these genes are viable but unable to mate. The other Sir gene, SIR! partially affects 
silencing and mating (Haber 1998). 
Cis-acting sequences are also needed for silencing at the HM loci. The sequences involved 
flank HML and HMR, and they are called silencers. The silencer on the left of a given HM 
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locus is designated as E, and the silencer on the right is designated I (Abraham et al. 
1984)(Fig. 5). Analyses of expression of plasmid-bome HM loci have shown that the E sites 
are essential for silencing, and deletion of I sites weakens silencing (Abraham et al. 1984; 
Feldman et al. 1984). However, in the genome, only deletion of HMR-E is able to disrupt 
silencing, whereas deletion of HMR-1 does not have an effect (Brand et al. 1985). 
Combinations of both HML-E and HML-1 deletions are needed to break silencing of the 
genomic HML locus (Mahoney and Broach 1989). 
Further dissection of the HMR-E silencer indicated that it contains three protein-binding 
sequences, called A, E and B (Brand et al. 1987)(Fig. 5). Deletion of one binding site has 
little effect on silencing, but combining any two deletions causes transcriptional 
derepression. E and B bind the proteins Raplp and Abflp, respectively. Sequence A is an 
ARS (autonomously replicating sequence), that binds ORC (origin replication complex). 
ORC recruits Sirlp, and Sirlp recruits Sir4p. Sir4p is also recruited by Raplp (Laurenson 
and Rine 1992; Huang 2002). 
Telomeric silencing. With a few exceptions, silencing at the telomeres is very similar to 
silencing at the HM loci. Sirlp does not participate in silencing at telomeres, but the other 
Sir proteins play similar roles as at HM loci (Aparicio et al. 1991). Within the telomeric 
repeat (Ci.3A)n, multiple Raplp binding sites are present (Buchman et al. 1988; Longtine et 
al. 1989). Also, in the sub-telomeric Y' and X repeat sequences, ORC and Abflp binding 
sequences are found (Chan and Tye 1983)(Fig. 5). Sir4p has been shown to bind to Raplp, 
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which is bound to the telomeric repeats, and this binding is independent of other Sir proteins 
(Luo et al. 2002). 
A model for silencing. A simple model for silencing is the following (Fig. 6): the DNA 
binding proteins Raplp, ORC, and Abflp recognize the silencers, and then they recruit Sirlp 
(only at the HM loci) and Sir4p to initiate silencing. After that, Sir2p, Sir3p, and Sir4p bind 
to the nucleosomes and to each other. The binding starts with Sir4p at the initiation site, and 
binding extends outward to form the heterochromatin domain. Two-hybrid experiments have 
shown that Sir4p interacts directly with Raplp, Sir2p, Sir3p, and itself; Sir3p and Sir4p 
interact with deacetylated histone H3 and H4 N-terminal tails (Luo et al. 2002). Sir2p is a 
histone deacetylase (Imai et al. 2000). This function suggests that Sir2p's role in maintaining 
and establishing silent chromatin is to deacetylate H3 and H4 and make possible the 
interaction of Sir3p and Sir4p with the nucleosomes. This recruitment model contains a 
positive feedback loop: binding of Sir3p and Sir4p to histones recruits Sir2p, and Sir2p 
deacetylates the next histones, facilitating Sir3p and Sir4p binding. 
The recruitment model assumes that the reiterated binding of Sir proteins and histones makes 
a huge complex and condenses the chromatin. In this way, heterochromatin blocks the 
access of the transcription machinery and represses gene expression. This assumption is 
supported by the observation that heterochromatin is inaccessible to digestion by micrococcal 
nuclease (Nasmyth 1982). However, more recent results demonstrated that the pre-initiation 
complex for transcription (TBP plus Pol II) occupies the promoters of genes located in 
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heterochromatin (Sekinger and Gross 2001). Hence, the assumption that genes are not 
accessible to transcription factors is obviously oversimplified. 
The recruitment model is generally satisfactory to explain the maintenance of transcriptional 
repression at silent loci. Experiments have shown the silencer sequences are dispensable 
when the proteins are recruited by other means. For example, a marker gene at HMR is 
derepressed when any two or all three protein binding sites in HMR-E are deleted. 
Repression is restored when Sirlp is tethered to the silencer (Chien et al. 1993). This implies 
that establishment of silencing is as simple as the model suggests. However, there are some 
observations pertaining to establishment that cannot be explained by the model. A SIR3 
temperature-sensitive mutation abolishes silencing at non-permissive temperatures, whereas 
silencing is reestablished at permissive temperatures. However, the restoration can only 
happen after passing through S-phase of the cell cycle (Miller and Nasmyth 1984). DNA 
replication was suggested to be involved in establishing silencing, since S-phase when DNA 
synthesis takes place. Seventeen years later, this possibility was excluded by using extra-
chromosomal rings carrying the HMR locus that cannot undergo DNA replication 
(Kirchmaier and Rine 2001 ; Li et al. 2001). The rings were able to resume silencing after S 
phase. The requirement for passage through S phase remains puzzling. 
The other issue unexplained by the recruitment model, is the inheritance of silencing. There 
are two states for expression of a gene located in silent chromatin: on or off. In the 
overwhelming majority of the cases at the HM loci, expression is off. Either transcriptional 
state is inherited through cell division. Switching between the two states happens at a very 
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low frequency. In sirl mutant strains, the phenotype of partial loss of silencing is actually a 
mixture of cells in both transcriptional states. With respect to HML, 80% of cells are 
derepressed and 20% are repressed in sirl strains (Pillus and Rine 1989). Both expression 
states are still inherited, although the switch rate is higher than in wild type strains. 
Obviously, epigenetic information has to be duplicated to the progeny cells through mitosis, 
and the mechanism by which this occurs is not yet part of the recruitment model. 
Other factors that influence silencing. Many proteins other than the ones mentioned above 
are involved in silencing, and the list is still growing. Riflp and Rif2p compete with Sir3p 
for Raplp interactions and hence negatively regulate telomeric silencing (Hardy et al. 1992; 
Wotton and Shore 1997). Sumlp and the Sir2p homolog Hstlp represent an alternative way 
of silencing at HM loci, because they can suppress sir mutants (Sutton et al. 2001). Sir 
proteins have also been demonstrated to participate in DNA repair by non-homologous end-
joining (NHEJ) (Tsukamoto et al. 1997; Boulton and Jackson 1998). When this happens, the 
Sir proteins mobilize from the telomeric reservoir to break sites, and this weakens telomeric 
silencing (McAinsh et al. 1999). Ku proteins, which are needed for NHEJ, are also 
associated with telomeres and positively regulate silencing. The redistribution of Ku and Sir 
proteins requires passing from G1 to S phase of the cell cycle and is dependent on the DNA 
damage checkpoint pathway (Martin et al. 1999; Mills et al. 1999). As a consequence, many 
proteins in the DNA damage pathway, such as Meclp, Mrclp, are indirectly involved in 
telomeric silencing. 
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As stated above, the hypoacetylation of histones in silent chromatin is required for gene 
repression, and hence proteins for histone acetylation (HATs) and deacetylation (HDACs) 
are entangled in silencing. Deletion of HDACs, namely HDA1 and RPD3, and other genes in 
the Rpd3p HDAC complex (e.g. S IN3, SDS3 and PH023) increases repression at all silent 
regions (Rundlett et al. 1996; Vannier et al. 1996). Two HATs, Sas2p and Sas3p, play roles 
in repression (Reifsnyder et al. 1996). Sas2p pairs with Sir2p to control the expression of 
telomeric regions (Kimura et al. 2002; Suka et al. 2002). Other histone modification factors 
such as Rad6p, Dotlp, Setlp, and Set2p affect silencing directly or indirectly by changing 
the histones locally or globally (Huang 2002). Interestingly, the chromatin assembly factor 
CAF-I and the DNA replication factor PCNA are also involved (Monson et al. 1997; 
Enomoto and Herman 1998; Shibahara and Stillman 1999; Zhang et al. 2000). This 
observation provides a possible picture of how epigenetic memory is transmitted after DNA 
and chromatin replication. 
Silencing at the rDNA. Transcriptional silencing at the rDNA repeats only needs Sir2p and 
not the other Sir proteins. At the rDNA, there are two other factors, Netlp and Cdcl4p, that 
form a complex with Sir2p (Shou et al. 1999; Straight et al. 1999). Netlp recruits Sir2p to 
the rDNA repeats. In a strain with a sir4-42 mutation, Sir3p and Sir4p are located at the 
rDNA (Kennedy et al. 1997). Although the mechanism of rDNA silencing is yet to be 
understood, the basic framework will likely be similar to silencing at other sites. 
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Ty5 targeting 
The intact Ty5 retrotransposon has a genome of 5.4 kb including two 251 bp LTRs. Ty5 has 
a single long ORF, which encodes Gag, IN and RT (Voytas and Boeke 2002). The 
polyprotein is processed by a Ty5-encoded protease (PR) activity. IN and RT are estimated 
to be 80 kD and 59 kD respectively, while Gag has two forms of 37 kD and 27 kD (Irwin and 
Voytas 2001). 
In the S288c strain of S. cerevisiae, there is one non-functional copy of Ty5 located at the 
telomere of chromosome III as well as a few solo LTRs. Five of the solo LTRs are 
associated with telomeres and the other two with HMR. An active copy of Ty5 was retrieved 
from the closely related species S. paradoxus. Numerous Ty5 insertions are found in the S. 
paradoxus genome, and most are also located in silent chromatin (Zou et al. 1995). 
The functional Ty5 was modified so that expression is driven by a galactose inducible 
promoter. A HIS3 gene was inserted in reverse orientation after the stop codon of RT. An 
artificial intron (AI) was inserted in this HIS3 gene in the correct orientation to be spliced 
from the Ty5 transcript (Fig. 7). This marker gene is advantageous for indicating reverse 
transcription and integration because it is not active until the AI is removed after Ty5 is 
transcribed, spliced, and reverse transcribed to cDNA. To gain stable expression, the cDNA 
must also be integrated. Fortunately, the marker's expression is not completely blocked by 
silent chromatin (Gottschling et al. 1990), and HIS3 only needs very low expression to confer 
a His+ phenotype. When Ty5 inserts into silent chromatin, the marker is still readily 
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selectable. Transposition assays show that the Ty5 transposes at a very low efficiency (10"6 
to 10"4 per element per cell). The new transposition events demonstrate a strong preference 
to integrate in silent chromatin: all but one of 19 events on chromosome III were within silent 
chromatin (Zou et al. 1996) (Fig. 8). 
About 10% of Ty5 integration events occur near HMR (Zou and Voytas 1997). As 
mentioned above, HMR-E contains three protein-binding sites (A, E and B) that are essential 
for silencing. Combinations of deletions in these sites were tested for Ty5 targeting. 
Correlated with silencing, the targeting to hmr loci with mutant silencers was reduced from a 
few to more than fifteen fold (Zou and Voytas 1997). The data suggested that the chromatin 
state is the key for targeting. To clarify this hypothesis further, strains with deletions in the 
core components of silencing, namely SIR2, SIR3, and SIR4 were tested (Zhu et al. 1999). A 
number of Ty5 insertions in the strains were analyzed. Ty5 lost target specificity in the sir3 
and sir4 strains as expected. However, the sir2 mutant still had half of the Ty5 insertions 
targeted, although sir2 mutations disrupt silencing as effectively as sir3 and sir4 mutations. 
This observation implies that targeting does not depend on the silencing itself, but rather 
certain proteins that participate in silencing (e.g. Sir3p or Sir4p). This is supported by a 
further observation: the rDNA region, which has Sir2p as a constituent, is not a favored 
target for Ty5. Sir3p and Sir4p are not normally located in the rDNA, but they are in a sir4-
42 strain, which expresses a C-terminal truncation of Sir4p. In sir4-42 strains, Ty5 
integration to the rDNA (10% of the genome) increased from 3% to 26% (Zhu et al. 1999). 
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Interestingly, not only does Ty5 integration favor silent chromatin, but so does recombination 
of Ty5 cDNA to its genomic homologues (Ke and Voytas 1999). This was shown by first 
preventing integration by mutating the signature residues (DDE) of the integrase catalytic 
domain. Two strains with Ty5 inserted at silent chromatin and euchromatin, respectively, 
were used for the analysis. Ty5 cDNA was found to recombine with the substrate in silent 
chromatin at least three times more frequently than in euchromatin. The preference 
depended on the Ty5 targeting function: the mutation (M3, see below), that abolishes Ty5 
targeting also abolishes the recombination preference. Therefore, we hypothesize that the 
Ty5 PIC containing IN and cDNA is recruited to silent chromatin, possibly by Sir3p or Sir4p. 
The consequence of recruitment is the bias in integration and cDNA recombination. 
To investigate the Ty5-encoded factors required for targeting, a targeting assay was designed 
by Xiaowu Gai, a former student in our laboratory (Gai and Voytas 1998)(Fig. 9A). A 
special yeast strain is used in the assay that has the RAD52 gene deleted to prevent 
homologous recombination. Ty5 on a plasmid is transformed into the strain and cells with 
integration events are selected by the HIS3 marker (Fig. 7). Another plasmid — the target 
plasmid -- is also present in the cell to indicate the targeting bias. This plasmid has the HMR 
locus and an ADE2 marker. Silencing at HMR makes this plasmid a favorite Ty5 target. The 
ADE2 marker is used to show the presence of the plasmid by the difference of the colony 
color. The strain is ade2, and colonies are red because they accumulate an adenine 
precursor; the colonies with the plasmid are white. The plasmid is quickly lost without 
selection pressure. This is due to the antagonism between the two DNA replication origins — 
the CEN and the ARS in HMR-E. Therefore, when an integration event occurs on the target 
18 
plasmid, the selection for histidine will select the plasmid with the ADE2 marker. 
Consequently, the colonies will be white. On the contrary, a genomic integration event will 
lead to a red or sometimes sectored colony (in cases where the plasmid is not lost in some 
cells). For a wildtype Ty5, the ratio of the white to red colonies is consistently 8-10% (Fig. 
9B). 
To identify Ty5 mutants with altered targeting specificity, the Ty5 genome was randomly 
mutagenized and screened by the targeting assay. One targeting mutant, M3, was identified 
out of 3000 Ty5 clones. M3 decreased the frequency of white colonies to 0.5% (-20 fold) 
(Fig. 9B). The phenotype was confirmed by sequencing ten Ty5 insertions in the genome, 
none of which was associated with silent chromatin. The M3 mutation is located at the 
border of the IN C-terminus and the RT N-terminus, a region not conserved in other 
retrotransposons. The results suggest that Ty5 encodes the targeting function, possibly at the 
IN C-terminus. 
At this point I started my thesis work and set out to address the following specific aims: first, 
to define the Ty5 determinants in charge of targeting; then to characterize the host factors 
that interact with these determinants; finally, to clarify the mechanism of Ty5 target 
specificity. 
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Dissertation organization 
Chapter II of my dissertation is a paper published in Molecular and Cellular Biology. In this 
paper, the targeting domain (TD) of Ty5 integrase was defined and shown to be a functional 
unit. I mutagenized the Ty5 integrase-reverse transcriptase boundary region and screened for 
targeting mutants with the help of Xiaowu Gai (co-author). The mutations comprise of a 
short motif (6 aa). Xiaowu performed the tethered silencing assay to show TD interacts with 
silent chromatin. Yunxia Zhu and David Zappulla (from Rolf Sternglanz's lab, SUNY Stony 
Brook) showed TD interacts with the Sir4p C-terminus. We obtained from the Stemglanz lab 
the strains for tethered silencing and two-hybrid tests. I purified the GBD-TD fusion from 
yeast and showed it bound to Sir4p in vitro. In addition, I determined that TD is part of 
integrase and not RT. Finally, I carried out all additional experiments necessary for the 
publication of this manuscript. 
In Chapter III, I demonstrated that TD is phosphorylated. DUN1 and other candidate genes 
were identified that affect Ty5 targeting. In this work, Junbiao Dai characterized the kinases 
involved in TD phosphorylation by using the three assays (tethered silencing, two-hybrid and 
disrupting silencing); these assays were developed in my first paper (Chapter II). Troy Brady 
helped me test some TD mutants by two-hybrid assays. 
In the last chapter, I provide general conclusions and point out some information that is not 
included in the papers and is worth mentioning regarding future work. 
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Figure 1. The genomes of transposons and retrotransposable elements. The 
boxes with arrowheads inside are to show the repeated sequences at the ends of 
the elements. A DNA transposon has inverted repeats. Retrotransposons and 
retroviruses have long terminal repeats (LTRs). Patterns of the boxes show the 
similarity among the genes. The endonuclease(EN) activity encoded by the 
transposase, or integrase (IN) is essential for all the elements. The reverse 
transcriptase (RT) gene is conserved for the retroelements. The protease (PR) 
activity is conserved for the LTR retroelements. 
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Figure 2. Life cycle of retrotransposons and retroviruses. A cell (the square) and 
its nucleus (the big circle) are shown. A circle with an octagon represents a virus­
like particle. Steps specific to the retroviruses are in italics. 
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Figure 3. The integration reaction of a LTR element. The nucleophilic attacks by 
H20 or by the exposed 3' hydroxy I of the LTR ends are indicated. The 
phosphodiester bonds in the acceptor DNA strands are shown by the small letter 
P. In the third step, the mismatched nucleotides are removed and the gaps are 
filled by the host DNA repair system. This step results in the target site duplication 
(TSD). The conserved LTR end sequences are shown. 
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Figure 4. Conserved domains of the integrases of the retrovirus HIV and the 
retrotransposons Ty1 and Ty5. The conserved HHCC residues for the zinc finger 
domain and DDE signature for the catalytic domain (shaded gray) are shown. 
NLS indicates the location of the Ty1 nuclear localization signal. M3 is the 
targeting mutation of Ty5. 
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Figure 5. Structure of the telomeric and HM silencers. The protein binding 
sequences are shown for the silencers (open boxes). The silencing state is 
represented by the shadow of dark orange. Rap1 p, repressor activator protein 1 ; 
Abflp, ARS-binding factor 1; ORG, origin recognition coplex; ARS, autonomously 
replicating sequence. [Redrawn from Lustig 1998, Curr Opin Genet Dev 8, 233-
239.] 
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Figure 6. The model of yeast telomeric silencing. The silencing is initiated at a 
telomeric repeat, which recruits Raplp then Sir4p. The nucleosomes in silent 
chromatin are condensed and hypoacetylated. Sir2p is recruited by Sir4p. It 
deacetylates H3 and H4 and thus facilitates Sir3p and Sir4p binding to the 
nucleosomes. The nucleosomes in non-silent chromatin are less condensed. 
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Figure 7. Transposition assay. A GAL promoter is used to replace part of the 5' 
LTR, which makes the element expression inducible on galactose media. Only 
after a new insertion of the element, can the cell grow on His- media. SD, splicing 
donor; SA, splicing acceptor. 
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Figure 8. Ty5 integrates preferentially into yeast heterochromatin. The red arrows 
indicate the locations of new integration events on chromosome III. The regions of 
left telomere, HML and HMR loci are enlarged to show the detailed locations of the 
insertions. The closed arrowheads are to show the native Ty5 LTRs. 
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Figure 9. The targeting assay. A. A diagram of the assay. Expression of an 
episomal Ty5 element is induced. The new cDNA can be integrated either to a 
chromosome or to the target plasmid. The fate of the integration is indicated by 
the color (white or pink) of a colony in a selective plate (His-). B. The results of the 
wildtype Ty5 and the M3 targeting mutant transposition. For the wildtype, the 
percentage of white colonies is about 8%, and for the mutant, it is 0.5%. 
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CHAPTER II. TARGETING OF THE YEAST TY5 RETROTRANSPOSON TO 
SILENT CHROMATIN IS MEDIATED BY INTERACTIONS BETWEEN 
INTEGRASE AND SIR4P 
A paper published in Molecular and Cellular Biology& 
Weiwu Xie1, Xiaowu Gai1, Yunxia Zhu1, David C. Zappulla2, Rolf Sternglanz2, 
and Daniel F. Voytas1 
Abstract 
The Ty5 retrotransposons of Saccharomyces integrate preferentially into regions of silent 
chromatin at the telomeres and silent mating loci (HMR and HML). We define a Ty5-
encoded targeting domain that spans six amino acid residues near the C-terminus of integrase 
(LXSSXP). The targeting domain establishes silent chromatin when tethered to a weakened 
HMR-E silencer, and it disrupts telomeric silencing when overexpressed. As determined by 
both yeast two-hybrid and in vitro binding assays, the targeting domain interacts with the C-
terminus of Sir4p - a structural component of silent chromatin. This interaction is abrogated 
by mutations in the targeting domain that disrupt integration to silent chromatin, suggesting 
that recognition of Sir4p by the targeting domain is the primary determinant in Ty5 target 
specificity. 
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Introduction: 
The long terminal repeat (LTR) retrotransposons are a large and ubiquitous class of 
mobile genetic elements. Like their cousins the retroviruses, they replicate by reverse 
transcribing an element mRNA and then integrating the cDNA product into their host's 
chromosomes. LTR retrotransposons are typically abundant components of nuclear 
genomes, constituting a few percent of the Saccharomyces cerevisiae genome to over 50% of 
the genomes of some plants such as maize (30, 44). As the genome sequencing projects 
progress, it is apparent that most retrotransposons are not randomly distributed on 
chromosomes. In Drosophila melanogaster and Arabidopsis thaliana, for example, 
retrotransposons are highly enriched in the pericentromeric heterochromatin (18, 43). This 
non-random distribution may be the result of preferential integration to these sites. It has 
been suggested that the low gene density of heterochromatin may offer a safe haven for 
transposition, which ensures persistence of retrotransposons by avoiding the harmful 
consequences of mutations that might occur if integration were random (4). Because 
repetitive sequences can form heterochromatin in some species, the accumulation of 
retrotransposons in certain regions of the genome may, in turn, contribute to the formation of 
chromatin domains (17). 
How is it that retrotransposons identify certain chromosomal regions during 
integration? One model suggests that the integration apparatus recognizes specific chromatin 
states or DNA-bound protein complexes (6). This tethers the integration machinery to target 
sites and results in the observed target site biases. This model is best supported by studies of 
the S. cerevisiae retrotransposons (Tyl-Ty5). Over 90% of native Tyl-Ty4 insertions are 
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located upstream of genes transcribed by RNA polymerase III (RNAP III) (30). These 
regions are often gene-poor, and like heterochromatin, may provide a safe haven for 
transposition within the streamlined S. cerevisiae genome (4). For Tyl and Ty3, the 
association with sites of RNAP III transcription is due to targeted integration. Targeting 
requires assembly of the RNAP III transcription complex, and promoter mutations in target 
genes that prevent transcription complex assembly render them inefficient targets (7, 8, 12). 
In vitro targeted transposition assays have been developed for Ty3 in which binding of 
TFIIIB and TFIIIC to tRNA gene templates is sufficient for targeting (31). The critical 
factors within these complexes appear to be the TATA binding protein and Brf (also called 
TFIIIB70) (49). These data support the model that targeting results when the retrotransposon 
preintegration complex recognizes specific DNA-bound proteins. 
In contrast to the other S. cerevisiae retrotransposons, native Ty5 elements are not 
located at sites of RNAP III transcription. Rather, like retrotransposons in many other 
organisms, Ty5 insertions are predominantly found within the heterochromatin-like domains 
of the S. cerevisiae genome, such as at the telomeres and silent mating loci (HMR and HML) 
(56). The chromatin at these sites is referred to as silent chromatin, because it represses 
transcription of genes located in these regions. Silent chromatin is made up of a large 
number of proteins that assemble at specific DNA sequences (reviewed in (34, 35). Several 
proteins or protein complexes bind the E and I silencers that flank HMR and HML, including 
the origin recognition complex (ORC), the transcription factor Abfl and the 
repressor/activator protein Raplp. These proteins also bind to sequences near the telomeres: 
ORC and Abfl bind to the subtelomeric X repeat, and Raplp binds to the telomeric repeat 
sequences (TG1-3). These DNA-bound proteins recruit additional components of silent 
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chromatin, including the well-studied Sir proteins. Sir2p is a histone deacetylase (20, 32, 
46), and Sir3p and Sir4p are considered structural components of silent chromatin. All three 
proteins interact with each other, and they nucleate at the silencers and spread outward along 
the chromosome (16, 39). 
Ty5 integrates preferentially into regions of silent chromatin. Over 95% of de novo 
Ty5 transposition events occur within a 3 kb window on either side of the HM silencers or 
the subtelomeric X repeat (53, 54). Silent chromatin is required for this target choice, 
because mutations in HMR-E that prevent its assembly abolish targeting to this locus (55). 
Targeting decreases by approximately 50% in sir2A strains, whereas it is virtually abolished 
in sir3A. or sir4A strains (52). An allele of SIR4 (sir4-42) causes a dramatic change in the 
chromosomal distribution of the Sir complex (28). In sir4-42 strains, Sir3p and Sir4p move 
from the telomeres and silent mating loci to the rDNA (29). This change in Sir protein 
distribution is related to mother cell aging, and sir4-42 strains are long-lived (28). Ty5 target 
specificity changes with the chromosomal distribution of the Sir complex in sir4-42 strains, 
and over 25% of the insertions occur within the rDNA (52). These results suggest that the 
Sir complex, particularly Sir3p and Sir4p, determines Ty5 target choice. 
Ty5-encoded proteins are also important for target site selection. A Ty5 missense 
mutation decreases targeting more than 20-fold and provides the first direct evidence that 
retroelements encode their own targeting determinants (13). In this paper, we further define 
Ty5-encoded factors required for targeting and describe a short targeting domain near the 
integrase C-terminus. This targeting domain interacts with silent chromatin, because when 
tethered to a defective HMR-E silencer, reporter genes at HMR are transcriptionally silenced 
in a Sir-dependent fashion. Overexpression of the targeting domain disrupts telomeric 
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silencing, likely by titrating away critical silencing components. We show that the targeting 
domain interacts with Sir4p in both yeast two-hybrid and in vitro binding assays. Sir4p, 
therefore, appears to be the primary host determinant mediating Ty5 target specificity, and 
the interaction between the Ty5-encoded targeting domain and Sir4p appears to determine 
target choice. 
Materials and Methods: 
Mutagenesis of Ty5 elements 
A BspEl-PflMI fragment of Ty5 (Figure 1) was mutagenized by PCR, using two 
different protocols to minimize mutation biases. The first used the nucleoside triphosphate 
analogue dPTP, which pairs with both A and G and thereby increases the mutation spectrum 
(50). A typical 20 pi reaction included 5 ng of template DNA (pXW27, a plasmid containing 
the BspEl-PflMI fragment), 2.5 units of Taq polymerase, 2 jil of lOx buffer, 0.5 p.1 of the 
universal and reverse primers (20 mM), 1.6 |il of 25 mM MgClz, 4 |iil of dNTPs (2.5 mM 
each) and 2.5 |il of dPTP (400 |iM). The PCR reaction was carried out for 5 cycles as 
follows: 92°C for 1 minute, 50°C for 1.5 minutes and 72°C for 5 minutes. An aliquot of the 
reaction (0.5 p,l) was then used for PCR amplification without dPTP (3). The second 
mutagenesis method used Mn2+ (rather than Mg2+) and biased amounts of dNTPs (45). A 
typical 50 |il reaction included 5 ng of template DNA, 2.5 units of Taq polymerase, 5 (xl of 
lOx buffer, 0.5 pi of each primer (20 mM), 14 |il of 25 mM MgClz, 0.75 |il of 10 mM 
MnCl2, 4 jLtl of dNTPs (2.5 mM each), 4\i 1 of dCTP (10 mM) and 4 |xl of dTTP (10 mM). 
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The PCR reaction was carried out for 13 cycles as follows: 94°C for 30 seconds, 50°C for 45 
seconds and 72°C for 3 minutes. An aliquot of the reaction (0.5 jul) was used as a template in 
a standard PCR amplification (3). The mutant Ty5 library was constructed by replacing the 
mutagenized BspEl-PflMI fragment with the corresponding fragment in a wild type Ty5 
element on pNK.254 (26). 
Mutations were made by PCR-based site-directed mutagenesis to define the targeting 
domain. pNK254 was PCR-amplified using the reverse primer and a mutagenic primer. The 
amplification product was digested with EcoRl and then inserted into the EccRl site of 
pWW37 - a Ty5 subclone containing a Hpal-Sacl fragment. The BspEl-PjlMl fragment of 
the recombinant plasmid was used to replace the corresponding fragment in pNK254. The 
mutagenic primers were as following: DV0754 for mutant pWW39 (5'-GGA-ATT-CAA-
TCG-AAT-CTC-CTC-CAT-CGG-TGG-ATT-CAT-C), DV0755 for mutant pWW40 (5'-
GGA-ATT-CAA-TCG-AAT-CTC-CTC-CAT-CGT-TGG-CTT-CAT-CGC-C, DV0756 for 
mutant pWW41 (5 ' -GGA-ATT-C AA-TCG-AAT-CTC-CTC-C AT-CGT-TGG-ATT-C AT -
CGG-CTC-CAA-ATA-C), DV0757 for mutant pWW42 (5 '-GGA-ATT-C AA-TCG-AAT-
CTC-CTC-CAT-CGT-TGG-ATT-CAT-CGC-CTC-CAG-CTA-CCT-CAT-TT), DV0631 for 
mutant pXWl 98 (5 ' -GGA-ATT-C AA-TCG-AA(T/G)-CTC-CTC-CA(T/G)-CGT-TGG-AT), 
DV0632 for mutants pXW199, pXW200 and pXW201 (5 ' -GGA-ATT-C AA-TCG-A AT-
CT(C/G)-CT(C/G)-CAT-CGT-TG), DV0634 for mutant pXW202 (5 '-GGA-ATT-CGG-
TCG-AAT-CTC-CTC-CAT-CGT-TGG-ATT-CAT-CGC-CTC-CAA-AT(A/G)-CC(T/G)-
CAT-TTA-AC). 
The Ty5 mutants rut-3, rut-15, rut-31, rut-38, rut-41, and rut-46 were constructed by 
replacing an EcoRl-PflMl fragment of the wild type Ty5 element on pNK254 with the 
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corresponding fragment from mutants ut-3, ut-15, ut-31, ut-38, ut-41 and ut-46. Because of 
the multiple EcoKl sites in Ty5, this was accomplished in two steps: first, an EcoRI-EcoRI 
fragment from the original mutant element was inserted into the EcoKl site of plasmid 
pWW37, which contains a Hpal-Sacl fragment of Ty5; secondly, the BspEl-PflMI fragment 
of the resulting plasmid was then used to replace the corresponding fragment of pNK254. 
For all mutant elements tested in this study, targeting was measured using our plasmid-based 
targeting assay described in detail in our previous study (13). 
Tethered silencing 
GBD fusion proteins were generated using pGBD plasmids, which contain the GAL4 
DNA binding domain under the control of the ADH1 promoter (23). The plasmid expressing 
GBD-INC (pXW140) contains amino acids 879-1136 of Ty5 inserted between the BamHl 
and Pstl sites of pGBDU; the GBD-inc construct (pXW158) is identical, except that it carries 
the S1094L mutation (13). The plasmid expressing GBD-TD (pXW205) was generated by 
inserting into the EcoRl-BgAl sites of pGBDU a short DNA fragment created from two 
complementary oligonucleotides DV0690 (5 ' - AAT-TCT-TGG-ATT-CAT-CGC-CTC-CAA-
ATA-CCT-CA) and DV0691 (5'-GAT-CTG-AGG-TAT-TTG-GAG-GCG-ATG-AAT-
CCA-AG); the GBD-td construct (pXW213) is identical, except that it has the S1094L 
mutation. Versions of these plasmids (pWW48, GBD; pWW49, GBD-TD; pWW50, GBD-
td) were generated in which the TRP1 marker gene was replaced with HIS3. This was 
accomplished by replacing the EcoRV-Xbal fragment with a ///Si-containing Nrul-Xbal 
fragment. LEU2-based expression plasmids (pWW44, GBD; pWW45, GBD-TD; pWW46, 
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GBD-td) were generated by swapping the GAD-encoding Sphl fragment from pGAD (which 
has the LEU2 marker (24)) with an Sphl fragment encoding the various GBD fusion proteins. 
To test silencing of the HMR reporter gene, the above expression plasmids were 
transformed into strains with different HMR-E mutations (9). These strains include YSB1 
(aeB no UASg), YSB2 (aeB::3X UASg) and YSB35 (Aeb::3X UASg). sir derivatives of 
YSB2 and YSB35 include RSI072 and RSI 12 (,sirl::URA3), RSI042 and RSI 132 
(sir2::URA3), RS1061 and RSI 133 (sir3::URA3) and RSI067 (sir4::URA3) (1). The strain 
used to assess telomeric silencing was UCC3505 (kind gift of D. Gottschling) (15). 
Complementation of GBD-TD-induced loss of telomeric silencing was tested by introducing 
SIR genes (kind gift of J. Rine) on 2 |iM plasmids (pRS424 (10)). The SIR2 plasmid 
(pSZ270) carries a Notl-Xhol fragment from pRS315-S7i?2, the SIR3 plasmid (pSZ282) 
carries a BamHl-Sall fragment from pJR104, and the SIR4 plasmid (pSZ269) carries a Sacll-
Clal fragment from pRS316-SIR4. To measure silencing, an overnight culture was grown to 
saturation for each strain and adjusted to OD6oo 1. Ten-fold serial dilutions were made; 10 |xl 
of each dilution were spotted onto both the test plate and the control plate. The plates were 
incubated at 30°C for two days. 
Two-hybrid assays 
Two hybrid assays were performed using yeast strain L40 (19), which has HIS3 and 
LacZ reporter genes under the control of upstream LexA operators. The LexA-SIR4C 
construct was previously described (2) and includes the C-terminal region of Sir4p (aa 950 to 
1358). Control strains expressed LexA from plasmid pBTMl 16 (4). GAD-INC fusions were 
constructed by inserting a Xmal-Pstl fragment from pXW140 into pGAD (23); the GAD-inc 
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construct is identical, except that it carries the S1094L mutation. The control expressed 
GAD from pGAD. Strains with the relevant plasmids were inoculated into 2 ml of selective 
media and shaken at 30°C for 24 hours. Ten-fold serial dilutions of the cultures were made 
and 5 pi of each dilution were plated onto SC-Trp-Leu or SC-Trp-Leu + 5 mM 3-amino-
1,2,4-triazole (3 AT) media; plates were incubated at 30°C for three days. 
Protein analyses 
Immunoblot analyses of Ty5 and GBD proteins were conducted as previously 
described using antibodies specific to the RGS-He tag (Qiagen) or GBD (Santa Cruz 
Biotechnology) (21). Two of the epitope-tagged Ty5 elements were described in this 
previous report (pWW32 and pIP19). The element with the targeting domain replaced by the 
RGS-H6 epitope (pWW59) was constructed by PCR mutagenesis (3). The Ty5 fragment 
within pWW37 (see above) was amplified using the universal primer, the reverse primer, 
DV01180 (5'-TG A-TGG-TGA-TGC-GAT-CCT-CTC-GAT-GGA-GGA-GAT-TCG-ATT-
G) and DV01181 (5 -CGC-ATC-ACC-ATC-ACC-ATC-ACA-ATA-CC T-CAT-TTA-ACG-
CGG-C). The BspEl-PflMI fragment contained within the amplification product was used to 
replace the corresponding fragment in the wild type Ty5 element carried on pSZ152 (53). 
To measure in vitro interactions between the targeting domain and Sir4p, we first 
constructed a plasmid expressing the C-terminus of SIR4 (aa 950-1358) by PCR-amplifying 
pSZ269 (see above) with primers DV01137 (5'-GAA-GGA-TCC-AGA-GGA-TCG-CAT-
CAC-CAT-CAC-CAT-CAC-AGA-AGA-GTG-TCG-CAT-AGT-G) and DV01085 (5'-TGA-
TCT-CGA-GTC-AAT-ACG-GTT-TTA-TCT-CC). The amplification product was digested 
with BamHl and Xhol and inserted into pCITE-2a(+) (Novagen) to generate pWW56. 
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pWW56 DNA (0.5 jug) was used in a 50 nl coupled transcription/translation reaction 
(Promega) containing 20 pCi 35S-methionine. GBD fusion proteins were immuno-affinity 
purified as previously described (40) from 250 ml yeast cultures (ODeoo 0.8-1.2) with either 
plasmid pXW205, pXW213 or pGBDU. Cells were harvested, washed with ice-cold water 
and resuspended in 1.8 ml lysis buffer B (50 mM HEPES pH 7.5, 0.5 M NaCl, 10% glycerol, 
0.1% IGPEL CA-630 (Sigma), 2 mM DTT, 2.5 mM benzamidine, 0.5 mM PMSF, 2 |Xg/ml 
leupeptin, 2 pig/ml bestatin and 2 |ig/ml pepstatin). Cells were disrupted by the glass bead 
method (3) and the lysate was centrifuged at 12,000 rpm at 4°C for 30 min. Levels of fusion 
protein in the supernatant were assessed by immunoblot analysis using anti-GBD antibodies 
(Santa Cruz Biotechnology). The GBD fusion proteins were immunoaffinity purified from 
300 pi of supernatant using 10 pi of an anti-GBD agarose-bead slurry (Santa Cruz 
Biotechnology). After a 2 hr incubation, the beads were collected by centrifugation (500Xg, 
2 min), washed twice with 300 pi of wash buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 5 
mM Mg(OAc)z, protease inhibitors) and once with IX PBS (137 mM NaCl, 2.7 mM KCl, 4.3 
mM NazHP04, 1.4 mM KH2PO4). The 50-jxl in vitro transcription/translation reaction 
containing the labeled Sir4p was then added to the washed anti-GBD agarose beads, and the 
mixture was incubated at room temperature for 30 minutes. The beads were collected by 
centrifugation (500Xg, 2 min) and washed three times with PBS. 10 pi of 2X SDS/sample 
buffer (3) was added to each tube; samples were heated (95°C for 10 min) and separated by 
SOS PAGE. The gel was dried and exposed to X-ray film overnight. 
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Results: 
Defining the Ty5 targeting domain 
We previously found that a single amino acid substitution at position 1094 in the Ty5 
polyprotein (S1094L) dramatically decreased targeting to the telomeres and silent mating loci 
(13). This indicated that Ty5 plays an active role in selecting targets and pointed to a 
possible targeting domain around S1094. To further define Ty5-encoded targeting 
determinants, a 758 bp BspEl-PflMI restriction fragment encompassing S1094 was 
mutagenized by PCR (Figure 1 A). The PCR products were used to replace the 
corresponding wild type fragment, and sequencing of several recombinants revealed that 
each carried 2-8 base pair changes. Over 2100 mutagenized elements were screened for 
targeting defects using our plasmid-based targeting assay, which we have previously shown 
is an effective measure of chromosomal integration patterns (13). In this assay, targeting is 
quantified as the percentage of integration events that occur at a plasmid-borne HMR locus. 
Eleven elements were identified that were impaired in targeting to varying degrees (Table 1). 
DNA sequencing revealed multiple nucleotide changes in the BspEl-PflMI fragments of 
these elements. Whereas some mutations were silent, the number of amino acid substitutions 
ranged from two (mutant ut41 and ut38) to eight (mutant ut46) (Table 1). 
We made three observations regarding the targeting mutants: 1) one mutant (ut5) had 
a S1094L substitution identical to the mutation described in our previous study; 2) all of the 
remaining mutants had an amino acid substitution in the vicinity of S1094 (encompassing a 
span of six amino acid residues); 3) independent mutations in the same residue near S1094 
had similar targeting defects (e.g. mutants ut23, ut31 and ut33). These observations 
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suggested that the mutations near S1094 were primarily responsible for the loss of target 
specificity. To test this hypothesis, seven new mutants were constructed that carried only 
one amino acid substitution near S1094 (Table 1). The S1094L mutation was not included 
because it was previously characterized (13). Targeting assays indicated that in all seven 
cases, the single mutations conferred a targeting defect nearly identical to the original 
mutants. This was the case even for conservative substitutions; for example, the LI092V 
mutation dramatically decreased targeting. Based on these data, we concluded that Ty5 
encodes a targeting domain (TO) and that it may be limited to a short stretch of six amino 
acids (LDSSPP). 
Because our mutagenesis recovered multiple substitutions in the same amino acid, 
this suggested that the mutagenesis of the PCR fragment was saturated. To confirm the 
boundaries of the targeting domain and to ensure that all critical amino acid residues near the 
LDSSPP motif had been identified, directed PCR mutagenesis was used to change residues 
near S1094 to alanine that were not identified as important for targeting. This included two 
residues (Asp 1093 and Pro 1096) that are located between other amino acids critical for 
targeting as well as residues upstream and downstream of the LDSSPP motif (Table 2). 
These substitutions had at most a modest effect on targeting (e.g. PI096, pWW41) or no 
effect at all (e.g. N1098, pWW42). It is interesting to note that each of the targeting mutants 
identified in this study had transposition frequencies from 2- to 6- fold lower than wild type 
(Table 1). In contrast, the mutants without altered target specificity transposed at near wild 
type levels (data not shown). This observation was also made in our original study wherein 
the S1094L mutation caused a 4-fold decrease in transposition (13). This indicates that 
targeting domain mutations also affect transposition efficiency. 
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The targeting domain is located in the integrate C-terminus 
Ty5 encodes a single open reading frame that is processed by a Ty5-encoded protease into 
several proteins, including integrase (IN; 80 kD) and reverse transcriptase (RT; 59 kD) (21). 
Extrapolating molecular weights from the Ty5 amino acid sequence, we predict the protease 
cleavage site that separates IN from RT is within the vicinity of the TD, and therefore the TD 
could reside either within the C-terminus of IN or within the N-terminus of RT. To 
distinguish between these possibilities, the TD was replaced with an epitope tag (RGS-He). 
Like the other TD mutants, the epitope-tagged element transposed more than 5-fold lower 
than wild type (data not shown). Proteins were prepared from strains expressing the TD-
tagged element (pWW59) as well as from control strains expressing elements with the same 
epitope at either the C-terminus of RT (pIP19) or within the middle of the IN coding region 
(pWW32) (Figure 1 A). Immunoblot analysis indicated that the element with the tag located 
at the targeting domain expressed a protein with the same mobility on SDS-PAGE gels as IN 
(Figure IB). Other tagged proteins revealed by immunoblotting represent various processing 
products or intermediates (21). All lanes contained equivalent amounts of total protein, yet 
levels of the TD-tagged IN were several-fold lower than the other tagged IN, suggesting that 
mutations in the TD may affect protein stability. Nonetheless, we could conclude from this 
experiment that the TD resides within IN, consistent with its role in target site selection. 
Tethering the targeting domain to DNA nucleates silent chromatin 
Our model for target specificity predicts that the TD interacts with silent chromatin to 
tether the integration apparatus to its target sites. If this is the case, then the converse may 
also be true: a targeting domain tethered to DNA may recruit silencing factors and establish 
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silent chromatin. To test this idea, an assay was utilized that evaluates a protein's ability to 
establish transcriptional silencing (9). The test protein was first fused to the Gal4p DNA-
binding domain (GBD), and the fusion protein was expressed in a yeast strain with a 
weakened HMR-E silencer that contains Gal4p binding sites (UASg). The effectiveness of 
the tethered proteins in nucleating silent chromatin was measured by the transcriptional status 
of a reporter gene at HMR (e.g. TRP1). Four Ty5-GBD fusion proteins were constructed 
(Figure 1C), one of which has 258 amino acids of the Ty5 integrase C-terminus (GBD-INC) 
and another which has only nine Ty5 amino acids (GBD-TD), six of which constitute the 
targeting domain. The remaining two fusion constructs differed only by the S1094L 
mutation (GBD-inc, GBD-td). Immunoblot analysis indicated that the wild type and mutant 
forms of the fusion proteins were expressed equivalently in yeast (Figure ID). 
The fusion constructs were introduced into yeast strains with two different HMR-E 
mutations: one lacked binding sites for ORG and Raplp (aeB), and the other lacked binding 
sites for Raplp and Abflp (Aeb) (9). The ability of the fusion proteins to establish silencing 
was measured by spotting 10-fold serial dilutions of the various strains onto media lacking 
tryptophan. The GBD-INC fusion was found to repress transcription over 100-fold (Figure 
2). Surprisingly, even the nine amino acid GBD-TD fusion protein silenced TRP1 more than 
10-fold. In both cases, the transcriptional silencing required the presence of the UASg, and 
in agreement with previous work (1,9), the fusion proteins were more effective at silencers 
with a wild type ORC binding site (Aeb). If the TD interacts with silent chromatin as 
predicted, then mutations that disrupt targeting should decrease its effectiveness in recruiting 
silencing factors (Figure 2C). Consistent with this hypothesis, both GBD-inc and GBD-td 
were unable to establish transcriptional silencing. All of the above observations were 
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confirmed in a strain with a URA3 reporter gene at HMR, indicating that the silencing was 
not reporter gene dependent (data not shown). 
Silent chromatin, by definition, requires the action of Sir2p, Sir3p and Sir4p. To 
determine whether the TD fusions establish silent chromatin or rather act in some other way 
to occlude the transcriptional machinery from the TRP1 promoter, the TD fusions were 
introduced into various sirA strains (9) (Figure 3). Sirlp was not required for TD-mediated 
silencing, consistent with its primary role in recruiting components of silent chromatin to the 
HM loci (47). However, the structural components of silent chromatin, Sir2p, Sir3p and 
Sir4p, were all required, indicating that the Ty5 TD represses the reporter gene at HMR by 
establishing silent chromatin. 
Overexpression of the targeting domain disrupts telomeric silencing 
Transcriptional silencing is very sensitive to the expression level of some components 
of silent chromatin. Overexpression of Sir4p, for example, disrupts telomeric silencing, 
presumably by titrating away other components of silent chromatin or by disrupting complex 
formation (22, 38) (See also Figure 4B). We tested whether overexpression of GBD-TD 
could disrupt telomeric silencing by monitoring the expression of telomeric (and therefore 
normally silenced) URA3 and ADE2 genes (15). Overexpression of GBD-TD (Figure ID) 
resulted in loss of telomeric silencing, as evidenced by the ability of cells to grow on media 
lacking uracil (Figure 4A). ADE2 expression was also evident by the white colony 
phenotype rather than the pinkish color characteristic of ADE2 repression and adenine 
precursor accumulation. As observed in the tethering experiments, expression of the fusion 
with the S1094L mutation did not affect telomeric silencing. 
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To test whether GBD-TD disrupts telomeric silencing by titrating away components 
of silent chromatin, the SIR genes were ectopically expressed by introducing them on high-
copy 2|i plasmids (Figure 4B). Overexpression of Sir4p by this means has previously been 
shown to disrupt telomeric silencing (38), and we made the same observation regardless of 
whether or not GBD-TD was co-expressed. Overexpression of Sir2p did not restore 
telomeric silencing to GBD-TD-expressing strains; however, it did increase telomeric 
silencing in GBD or GBD-td strains. In contrast, overexpression of Sir3p overcame the 
GBD-TD-dependent loss of telomeric silencing. This suggests that Sir3p is titrated away 
(either directly or indirectly) by interacting with the TD. Alternatively, excess Sir3p could 
dominantly restore silencing by bypassing a factor being titrated away by TD. In addition, a 
growth defect was observed on non-selective media when Sir3p and GBD-TD were co-
overexpressed (Figure 4B). 
Sir4p interacts with Ty5 integrase 
Several lines of evidence suggest that Sir3p and Sir4p are likely candidates for 
interacting with the Ty5 integrase to mediate target specificity: 1) targeting is largely 
abolished in sir3A and sir4A strains (52); 2) in sir4-42 strains, Ty5 integration specificity 
changes with the chromosomal localization of Sir3p and Sir4p; 3) as described above, loss of 
telomeric silencing due to overexpression of TD can be complemented by overexpression of 
Sir3p. To test whether Ty5 integrase interacts with Sir3p or Sir4p, two-hybrid assays were 
conducted. An interaction was detected between the C-terminus of Sir4p (SIR4C, aa 950-
1358 expressed as a LexA fusion) and the Ty5 integrase C-terminus (expressed as a GAD 
fusion). This interaction strongly activated the HIS3 reporter gene and enabled growth of 
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yeast cells on selective media (Figure 5A). Consistent with the role of the targeting domain 
in silencing, this interaction required a wild type TD: the S1094L mutation greatly weakened 
the two-hybrid interaction. These data indicate that integrase C-terminus binds to Sir4p 
(either directly or indirectly) and that the TD is required for this interaction. 
To confirm the two hybrid data, we tested whether the Sir4p C-terminus and the Ty5 
targeting domain could interact in vitro. GBD, GBD-TD or GBD-td were expressed in yeast 
and immunoaffmity-purified using anti-GBD agarose beads. Beads with the bound GBD 
proteins were incubated with SIR4C that had been labeled with 35S-methionine. The beads 
were washed, and the proteins eluted and separated by SDS-PAGE. Sir4p bound to GBD-TD 
— the fusion protein with the wild type targeting domain. Lower, background levels of 
binding were observed for GBD and GBD-td (Figure 5B). These in vitro data support the 
results obtained in the two-hybrid assays and collectively suggest that the biological activity 
of the targeting domain is mediated by interactions with Sir4p. 
Discussion: 
In a simple model to explain LTR retroelement target specificity, the interaction 
between the preintegration complex and DNA-bound proteins tethers the integration 
machinery to target sites and results in integration site biases (6). Support for this model 
comes from the study of the yeast Ty retrotransposons. These elements have different target 
preferences: Tyl and Ty3 prefer sites of RNAP III transcription (8, 12), and Ty5 prefers 
silent chromatin (55). In both cases, DNA-bound protein complexes are required for 
targeting. HIV integrase interacts with a human homolog of the transcription factor SNF5 in 
two hybrid assays (24); however, there is no evidence that this interaction mediates target site 
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choice. In this study, we define a Ty5-encoded targeting domain (LXSSXP) and show that it 
interacts with Sir4p, a component of silent chromatin. To our knowledge, this interaction 
between a retroelement-encoded protein and a chromatin factor provides the first direct 
evidence for the targeting model. 
The integrase C-terminus and the targeting domain 
Retrotransposon and retroviral integrases consist of three distinct domains (25): 1) an 
N-terminal region with a zinc-binding motif that is required for integrase activity and likely 
binds cDNA; 2) a catalytic domain that executes the integration reaction; and 3) a C-terminal 
region, which for the retroviruses and some retrotransposons, is required for cDNA 3'-end 
processing. The retrotransposon integrase C-termini are considerably larger than their 
retroviral counterparts; the Tyl and Ty5 C-termini constitute more than half of integrase (e.g. 
HIV IN is 288 aa; Tyl IN is 635 aa). Little is known about the function of the 
retrotransposon C-terminal extensions, with the exception that the very C-terminus of Tyl 
integrase encodes a nuclear localization signal that is required for the preintegration complex 
to gain nuclear access (27, 41). For Tyl and Ty5, the coding region of IN lies upstream of 
RT, and both are released from the polyprotein by proteolytic cleavage. In our earlier study 
of a Ty5 targeting mutant, we could not determine whether the targeting mutation was 
located in the C-terminus of IN or the N-terminus of RT (13). By replacing the targeting 
domain with an epitope tag and comparing its electrophoretic mobility to other tagged forms 
of RT and IN, we demonstrate here that the targeting domain resides within integrase. This 
indicates that integrase is responsible for target specificity and demonstrates a new function 
for the integrase C-terminus. For some members of the more distantly related Ty3/gypsy 
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group retrotransposons (Metaviridae), the integrase C-terminus encodes a chromodomain, a 
motif implicated in targeting proteins to chromatin (36). The integrase C-terminus, therefore, 
may generally be used by retroelements for integration site selection. 
Despite the large size of the integrase C-terminus, the Ty5 targeting domain identified 
through our mutant screen only spans 6 amino acid residues. This short domain is 
biologically active: when as few as nine amino acids encompassing the targeting domain are 
expressed as part of a fusion protein (e.g. GBD-TD), they nucleate silent chromatin or disrupt 
telomeric silencing. Fusion proteins expressing larger fragments of the IN C-terminus are at 
least 10-fold more effective in nucleating silent chromatin. This suggests that other regions 
of the IN C-terminus play a role in targeting. These regions may not have been identified by 
our mutant screen if they are required for transposition. Transposition defects were observed 
during characterization of several targeting mutants. For example, the transposition 
efficiency of mutant utl5 was more than 30-fold lower than wild type. This mutant had three 
missense mutations in the IN C-terminus in addition to the mutation in the targeting domain 
(Table 1). When the utl5 targeting domain was evaluated in isolation (see rati 5, Table 1), 
transposition was only 5-fold lower than wild type. Additionally, we observed that most of 
the mutagenized elements (-60%) were unable to transpose or showed greatly reduced levels 
of transposition (unpublished data). Some of these likely carry stop codons or frameshift 
mutations that prevent synthesis of the downstream RT; however, the frequency of non-
transposing elements was too high based on the extent of mutagenesis (-0.5%). This implies 
that regions of the C-terminus outside of the targeting domain are important for transposition. 
In addition to loss of target specificity, a second phenotype shared by all of the TD 
mutants is an overall decrease in transposition (2- to 6-fold). For wild type Ty5, more than 
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94% of Ty5 integration events occur within regions of silent chromatin, whereas the 
remainder appear to be randomly distributed throughout the genome (54, 56). If the TD is 
required for integration, then TD mutations should alter transposition frequencies. However, 
if the TD is required only for targeted integration, then the transposition frequencies would 
be predicted to drop ~ 15-fold (94% divided by 6%). The intermediate effect of TD 
mutations on transposition suggests that the TD plays a role beyond tethering the integration 
apparatus to its preferred target sites. Possibilities include facilitating the integration 
reaction, facilitating reverse transcription (which is supported by recent data indicating that 
the C-terminus of integrase is required to produce functional Tyl RT in vitro (48)), or 
facilitating nuclear localization (the Tyl NLS is located in approximately the same region of 
the protein as the Ty5 TD (27, 41)). In strains expressing a modified Ty5 in which the TD 
was replaced by an epitope tag, we observed significantly lower levels of integrase protein 
(Figure 1). It is also possible that a wild type TD is required for protein stability. 
The targeting domain and silent chromatin 
A large number of proteins are involved in the assembly and maintenance of silent 
chromatin (reviewed in (34, 35). These include proteins such as Sir3p and Sir4p that carry 
out structural or scaffolding roles, and proteins like Sirlp and Raplp that recruit and nucleate 
the structural proteins at the silencers. Tethering either class of these proteins to weakened 
HMR-E silencers effectively establishes silencing (9, 37). Likewise, the integrase C-terminus 
is very effective in nucleating silencing and causes a 100 to 1,000-fold decrease in the 
expression of reporter genes at HMR. The targeting domain does not simply recruit a protein 
complex that occludes the RNA polymerase II machinery from the reporter gene. Rather, it 
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establishes silent chromatin as defined by the requirement for Sir2p, Sir3p and Sir4p. TD-
mediated silencing does not need Sirlp, which primarily acts at HM loci and is not required 
for silencing at the telomeres or rDNA. At the HM loci, Sirlp interacts with ORC (47), and 
it is interesting to note that the TD is more effective when the ORC binding site is intact. 
This has also been observed with other nucleators of silent chromatin (1,9). Although a 
number of S. cerevisiae proteins have motifs that match the TD consensus (LXSSXP), none 
are known components of silent chromatin. 
We have previously shown that in contrast to sir3A and sir4A strains, targeting of Ty5 
to the telomeres and HM loci is only partially impaired in sir2A strains and occurs at levels 
approximately 50% of wild type (52). Furthermore, the loss of telomeric silencing caused by 
overexpressing the targeting domain cannot be restored by overexpressing Sir2p. In light of 
recent findings that Sir2p is a histone deacetylase (20, 32, 46), this suggests that the Ty5 
integration apparatus does not sense Sir2p-mediated acetylation patterns. The targeting 
defect in sir2A strains is likely rather a secondary consequence of perturbations in silent 
chromatin. In contrast, the loss of telomeric silencing caused by overexpressing the TD can 
be restored by additional SIR3 expression. The Sir4p C-terminus interacts directly with 
Sir3p, and it may be that overexpression of the TD disrupts this interaction, which, in turn, is 
stabilized by additional Sir3p. In that regard, it has been observed that loss of telomeric 
silencing caused by overexpression of the Sir4p C-terminus can be complemented by 
overexpressing Sir3p (14). Finally, it is important to note that the combined expression of 
Sir3p and a wild type TD causes a growth defect, indicating that although the TD may not 
interact directly with Sir3p, Sir3p does modulate the biological activity of the TD. 
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The targeting domain and Sir4p 
Prior to carrying out the two-hybrid assays, no evidence distinguished the roles of 
Sir3p and Sir4p in Ty5 target specificity. The only notable difference was that Ty5 cDNA 
recombination increased more than 10-fold in sir4à strains and was only marginally affected 
in sir3A strains (52). In strains with the sir4-42 allele, which expresses a C-terminally 
truncated form of Sir4p (aa 1-1237), Ty5 integrates preferentially into the rDNA (52). Here 
we demonstrate that the Ty5 targeting domain interacts with the Sir4p C-terminus (aa 950 -
1358), suggesting that the relevant region of interaction is located between amino acids 950 
and 1237. The Sir4p C-terminus interacts with many proteins, including Sir2p and Sir3p 
(40), Raplp (5, 42), Sif2p (11) and Dislp (51). Two hybrid interactions may result if one or 
more of these proteins serve as a bridge between the targeting domain and Sir4p. However, 
we have not observed two-hybrid interactions between integrase and other components of 
silent chromatin (data not shown). Furthermore, the observed in vitro binding between Sir4p 
and the targeting domain argues that these molecules interact directly. Nonetheless, because 
we used fusion proteins purified from yeast cells for these experiments, we cannot exclude 
the possibility that other factors co-purified or modified the TD to yield productive 
interactions. 
Concluding remarks 
Previous studies demonstrated that DNA bound in silent chromatin is inaccessible to 
proteins like HO endonuclease, restriction enzymes or transcription factors (33). However, 
the ability of Ty5 to integrate into silent chromatin suggests that this DNA is accessible to 
Ty5 integrase. Our model that target specificity results from simply tethering the 
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preintegration complex to chromatin may therefore require additional refinements. For 
example, the integration complex may induce changes in silent chromatin during integration, 
and the role of the targeting domain in such processes is an important area of future research. 
An increased understanding of targeting mechanisms may make it possible to 
manipulate retroelement target site choice. It may be possible to change the integration 
preference of retrotransposons by replacing targeting domains with peptide motifs that 
interact with specific chromosomal proteins. Such engineered retrotransposons may become 
useful tools for studying chromatin organization and may provide novel methods for genome 
manipulation. Retroviral vectors are widely used for DNA delivery in human gene therapy; 
however, uncontrolled, random integration into the host genome is one of their major 
drawbacks. It may now be possible to better control retroviral integration site choice to 
improve their efficacy as vectors for gene delivery. 
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Figure Legends: 
Figure 1. The Ty5 targeting domain is located at the C-terminus of integrase. (A) Ty5 is 
5375 bp in length. It expresses a full-length protein of 182 kD, which is processed by 
protease (PR) into Gag, integrase (IN) and reverse transcriptase (RT) (21). The cleavage 
sites, based on the mobility of mature proteins by SDS-PAGE, are shown by dashed lines. 
The black bar marks the position of TO. The BspEl and P/7MI sites define the region of 
integrase used in the mutagenesis experiment. pIP19, pWW32 and pWW59 carry Ty5 
elements that were modified by an RGS-HÔ tag. The tag replaced TD (pWW59) or was 
inserted either into the middle of IN (pWW32) or at the end of RT (pIP19) (21). (B) The 
modified Ty5 elements were expressed in yeast, and an anti-RGS-He antibody was used to 
identify IN or RT on immunoblots. The partially processed and mature protein species are 
indicated. (C) The Ty5 integrase fragments used throughout this paper are shown. INC and 
inc are 258 aa long (the small letters indicate the version with the S1094L mutation). TD and 
td represent the wild type or mutant targeting domain plus three flanking amino acids from 
Ty5. (D) Western blots demonstrating that the wild type and mutant GBD fusion proteins 
are expressed at comparable levels in the test strains (YSB2 and UCC3505). GBD-INC and 
GBD-TD have molecular weights of approximately 47kD and 19kD, respectively. 
Figure 2. The Ty5 targeting domain nucleates silent chromatin. (A) A cartoon depicting the 
tethered silencing assay. Yeast strains were used with deletions in two of the protein binding 
sites in HMR-E (A, E or B) and three copies of UASq - binding sites for Gal4p (9). In the 
example depicted, the E and B binding sites are deleted (e, b), resulting in derepression of 
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transcription at HMR. Expression of a fusion protein between GBD and the Ty5 targeting 
domain (GBD-TD) is tested for its ability to recruit components of silent chromatin and 
restore silencing. Silencing is measured by expression of the adjacent TRP1 marker gene. 
(B) Silencing was established when GBD-INC and GBD-TD were tethered to the weakened 
HMR locus by the triple UASq. Serial, 10-fold dilutions of cells were plated onto control 
(SC-Ura) or test (SC-Ura-Trp) media to measure silencing of the TRP1 reporter gene at 
HMR. (C) A point mutation that abolishes targeting fails to restore silencing for both fusion 
proteins (GBD-inc and GBD-td) in both test strains. 
Figure 3. Silencing conferred by the targeting domain is Sir-dependent. The assay system is 
described in the legend to Figure 2. In strains with deletions of SIR2, SIR3 or SIR4, GBD-TD 
fails to establish silencing at a weakened HMR locus. Silencing, however, does not require 
the SIR1 gene. The Ade" phenotype of the sir2A, sir3A and sir4A strains confers their dark 
color; the sirlA stain is Ade+. 
Figure 4. Overexpression of the Ty5 targeting domain disrupts telomeric silencing and loss 
of silencing is complemented by overexpression of Sir3p. Two reporter genes URA3 and 
ADE2 are located at telomeres VIIL and VR, respectively (15). URA3 expression was 
measured by growth of the yeast cells on selective media. ADE2 expression is indicated by 
colony color; when ADE2 is repressed, the colonies are red/pink. (A) Overexpression of 
GBD-TD disrupts telomeric silencing (i.e. restores URA3 expression) in contrast to its mutant 
form (GBD-td) and GBD alone. (B) Overexpression of Sir2p and Sir3p strengthen silencing, 
and Sir4p breaks silencing, as previously reported (22, 38). This is demonstrated in the GBD 
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control strains and GBD-td strains. When the targeting domain and SIR genes are 
overexpressed in the same strains, Sir3p, but not Sir2p or Sir4p, restores silencing. 
Figure 5. The C-terminus of the Ty5 integrase interacts with the C-terminus of Sir4p. (A) 
Yeast two-hybrid assays reveal an interaction between GAD-INC and LexA-SIR4C. Liquid 
cultures expressing the various LexA and GAD proteins were serially diluted 10-fold and 
spotted onto plates. A positive two-hybrid interaction is measured by transcriptional 
activation of the HIS3 reporter, which allows for growth on selective media (SC-Trp-Leu-His 
with 5 mM 3-amino-1,2,4-triazole, 3 AT). Activation of the HIS3 marker requires both 
SIR4C and the wild type targeting domain. (B) SIR4C interacts with GBD-TD in vitro. 
SIR4C was expressed and labeled with 35S-methionine by coupled transcription/translation. 
GBD-TD and GBD-td were expressed in yeast and immunoaffinity-purified with anti-GBD 
agarose beads. The top lanes indicate the amount of labeled SIR4C bound by the various 
GBD proteins. The bottom lanes are from an immunoblot performed with anti-GBD 
antibodies, and they indicate the levels of GBD proteins in the extract used for 
immunoaffinity purification. 
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Table 1. PGR mutagenesis defines the Ty5 targeting domain 
Element Transposition Transposition Percent Targeting No. of base Amino acid 
efficiency fold decrease targeted fold decrease changes0 sequence 
(io'Y transposition^ near S1094
d 
Wild type 13.3 ±2.8 1.0 7.9% 1.0 0 LDSSPP 
Mutants identified in the screen 
ut3 3.43 ±0.92 3.9 1.3% 6.1 4 SDSSPP 
ut29 0.97 ±0.11 13.7 1.4% 5.6 5 VDSSPP 
ut5 1.93 ±0.42 6.9 0.4% 19.8 5 LDLSPP 
ut35 0.52 ±0.08 25.6 0% NA 7 LDPSPP 
ut41 1.49 ±0.27 8.9 0.2% 39.5 2 LDPSPP 
ut38 1.14 ±0.22 11.7 1.1% 7.2 2 LDSLPP 
ut46 2.46 ±0.68 5.4 0.5% 15.8 8 LDSPPP 
utl5 0.44 ±0.19 30.2 0% NA 4 LDSSPL 
ut23 1.42 ±0.46 9.4 2.5% 3.2 5 LDSSPL 
ut31 1.55 ±0.02 8.6 1.8% 4.4 6 LDSSPQ 
ut33 1.40 ±0.06 9.5 2.1% 3.8 4 LDSSPQ 
Mutants with single amino acid substitutions in the vicinity of S1094 
rut3 2.40 ±0.10 5.5 0.7% 11.3 1 SDSSPP 
pWW39 ND 2.1 2.1% 3.8 1 VDSSPP 
rut41 2.12 ± 0.16 6.3 0.7% 11.3 1 LDPSPP 
rut38 2.25 + 0.66 5.9 1.1% 7.2 1 LDSLPP 
rut46 2.11 ±0.98 6.3 0.6% 13.2 1 LDSPPP 
rut 15 2.64 ± 0.23 5.0 3.0% 2.6 1 LDSSPL 
rut31 3.09 ±0.89 4.3 2.0% 4.0 1 LDSSPQ 
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"Data compiled from three independent experiments. 
^Number of transposition events to the target plasmid divided by total number of 
transposition events. For mutants indicated by 0%, transposition was too low OOto 
meaningfully determine the percent targeted transposition. 
cBase changes were identified by DNA sequencing of the BspEl - PflMl fragment from each 
of the mutants. 
dS1094 is in bold; missense mutations are underlined. 
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Table 2. Site-directed mutagenesis indicates that only four of the six amino acids in the 
Ty5 targeting domain are required for integration specificity 
Element Percent targeted 
transpositiona 
Amino acid sequence near the targeting domain b 
Wild type 7.9% SPPSLDSSPPNTS 
pWW40 7.0% SPPSLASSPPNTS 
pWW41 5.9% SPPSLDSSAPNTS 
pXW198 8.6% APPALDSSPPNTS 
pXW 199 8.0% SAPSLDSSPPNTS 
pXW201 8.2% SAASLDSSPPNTS 
pXW200 8.6% SPASLDSSPPNTS 
pXW202 7.9% SPP SLDSSPPN A A 
pWW42 7.8% SPPSLDSSPPATS 
aData compiled from three independent experiments. 
^Targeting domain is in bold; missense mutations are underlined. 
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CHAPTER III. KINASES REGULATE TARGETING OF THE YEAST RETROTRAN­
SPOSON TY5 TO HETEROCHROMATIN 
A manuscript to be submitted to Genes and Development 
Weiwu Xie, Junbiao Dai and Daniel F. Voytas 
Department of Zoology & Genetics, Iowa State University, Ames, IA 50011 
The yeast retrotransposon Ty5 preferentially inserts its cDNA into heterochromatin found 
at the telomeres and silent mating (HM) loci. We previously demonstrated that targeting is 
due to a large extent to a protein-protein interaction between a short domain (the targeting 
domain, TD) of Ty5 integrase and the silencing regulator Sir4p. The TD is only six amino 
acids in length (LDSSPP), and when it is expressed and immuno-purified from yeast cells, TD 
binds in vitro to the C-terminus of Sir4p (Sir4C). The TD, however, cannot bind to Sir4C 
when it is expressed and purified from E. coli, suggesting that it is post-translationally 
modified and that this modification is essential for binding. The modification is likely 
phosphorylation, because treatment of immuno-purified TD with Lambda protein 
phosphatase abrogates Sir4C binding. To further test if the two serines are phosphorylated, 
they were mutated individually and in combination to threonine or glutamate. TD can 
establish silencing when tethered to a crippled HM locus, and the mutant TDs established 
silencing to different degrees. We also introduced the single and double glutamate 
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substitutions into Ty5 and checked the target specificity of these mutants. Mutation of the 
second serine did not affect targeting, whereas mutation in the first serine hindered targeting 
moderately. When the two mutations were combined, targeting was still partially maintained, 
but was decreased relative to the single mutations. This data implies that the serines in the 
targeting domain are phosphorylated and that phosphorylation can be partially mimicked by 
a negatively charged amino acid. A yeast deletion collection was screened to identify the 
kinases that act on the targeting domain. A few candidate kinases were identified in two 
rounds of screening using a plasmid-based targeting assay. Dunlp, the DNA damage 
checkpoint kinase, affects Ty5 targeting and TD's ability to bind Sir4C. We suggest that 
Dunlp is the kinase that indirectly or redundantly modifies TD. 
[Key Words: Retrotransposon; target specificity; heterochromatin; phosphorylation; kinases] 
Introduction 
A retrovirus encodes reverse transcriptase (RT) and integrase (IN) for its propagation. RT 
copies the retroviral RNA genome into cDNA. IN inserts the cDNA into the host genome. 
After integration, host resources are exploited to synthesize new virus particles until the host 
cell is ultimately depleted and killed. Retrotransposons are closely related to retroviruses. 
They also use RT and IN to multiply. However, a retrotransposon has to comprise with its 
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host for one reason: retrotransposons do not encode envelope genes as do retroviruses, so 
they can not escape the host cell. Retrotransposons can only survive if the host survives. 
Saccharomyces cerevisiae accommodates five families of retrotransposons, designated Tyl-
Ty5. More than 80% of Tyl-Ty4 elements are found inserted in the upstream regions of 
genes transcribed by RNA polymerase III (Pol III), such as tRNA genes (Kim et al. 1998). 
Eight of the native Ty5 insertions in S. cerevisiae and 95% of newly integrated Ty5 elements 
are associated with silent chromatin (also called heterochromatin) (Zou et al. 1996). Silent 
chromatin includes the telomeres and HM loci. Regions surrounding Pol Ill-transcribed genes 
and silent chromatin are gene poor, and the observed target specificity suggests that yeast 
retrotransposons evolved a mechanism to avoid killing their host by avoiding disruption of 
genes. 
It has been shown that the Tyl and Ty3 preintegration complexes (PIC) require Pol III 
transcription factors to target cDNA insertion (Kirchner et al. 1995; Devine and Boeke 1996) 
Similarly, Ty5 requires a functional domain of heterochromatin to target effectively to silent 
regions (Zou and Voytas 1997). Heterochromatin is initiated by cis-acting sequences, the 
silencers, which bind the proteins Raplp, Abflp, and the origin recognition complex (ORC). 
The silent information regulators (Sirs) are then bound and extend along the chromatin by 
binding to the deacetylated histone H3 and H4 N-terminal tails (reviewed by (Lustig 1998)). 
Silencing extends until a silencing boundary is reached (Bi and Broach 2001). Sir2p has lately 
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been shown to be a histone deacetylase (Imai et al. 2000; Landry et al. 2000; Smith et al. 
2000), and Sir2p, Sir3p, and Sir4p are essential structural components of heterochromatin. 
Ty5 expresses a special domain in the end of the integrase, which is called the targeting 
domain (TD). TD interacts with one of the silent chromatin components, Sir4p, to guide its 
integration (Xie et al. 2001). 
In this paper, we show that the targeting of Ty5 is efficiently regulated by the host. Our 
results indicate that in order to be functional, TD needs to be phosphorylated by host 
kinases. Thus, the integration pattern of Ty5 could readily be changed by altering the 
kinases' activity. This regulation may benefit both the element and its host. In case of a 
dramatic change in the environment, the kinase activity may be inhibited, and Ty5 insertions 
will be randomized. The consequence of random insertion will be to accelerate evolution of 
yeast, making it better suited to the environmental change. 
Results 
In vitro binding ofTD to Sir4p is blocked by protein phosphatase. 
We have previously characterized the Ty5-encoded targeting domain (TD) and shown that it 
interacts with the Sir4p C-terminus and guides the PIC to heterochromatin resulting in Ty5's 
insertion preference. TD is only six amino acids long (LDSSPP), and the four bolded 
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residues are required for function, including the two serines (Xie et al. 2001). We have shown 
that when nine amino acids encompassing TD are expressed as a GBD fusion, they bind in 
vitro to the Sir4p C-terminus (Sir4C) (Figure 1 central panel). A mutant version of TD (td) 
with a leucine substituted for the first serine fails to bind Sir4C. In these experiments, the 
fusion protein was expressed and immuno-purified (using a GBD antibody) from yeast cells. 
However, when TD was fused to GST, then expressed and purified from the E. coli cells, it 
could not bind to Sir4C (Figure 1 left panel). We could not exclude the possibility that the 
upstream peptide (i.e. GST) blocked TD's function, although this was not the case when TD 
was fused to either GAD or lexA (Xie et al. 2001). The results suggest a difference between 
the TD from yeast cells and from E. coli cells. We hypothesize that the TD in yeast cells has 
been modified, perhaps through phosphorylation of the serines. We carefully examined our 
Western blots of the GBD-TD. Doublets of the bands were found always associated with 
the wild-type TD rather than the mutant TD or with GBD by itself (data not shown). This 
supports the modification hypothesis. To show TD is phosphorylated, the immuno-purified 
TD fusion protein from yeast was further treated with the X protein phosphatase before 
mixing with Sir4C. The binding decreased to the background level (Figure 1 right panel). 
Amino acid substitutions suggest serine phosphorylation ofTD. 
We have shown that a change in the four essential amino acids of TD, even a moderate change 
from leucine (1092) to valine, causes serious difference in Ty5 targeting (about a 4-fold 
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decrease based on our targeting assay) (Xie et al. 2001). Even so, we reasoned that the 
serines in TD might be able to be substituted by threonine (T) without a functional change in 
TD, if indeed TD is phosphorylated in vivo by certain serine/threonine kinases. 
Furthermore, the phosphorylation may be mimicked when the serines are substituted by a 
negatively charged amino acid, for example, by glutamate (E). 
The interaction of TD and Sir4C has been monitored in vivo by several assays: TD 
establishes silencing when tethered to a crippled HMR locus, TD overexpression breaks 
telomeric silencing, and TD and Sir4C interact in two-hybrid assays (Xie et al. 2001). We 
first tested amino acid substitutions in TD using the tethered silencing assay. In this assay, 
two protein binding sequences in the E silencer were deleted; thus the adjacent marker gene is 
not silenced (Chien et al. 1993). When a UASG sequence is inserted at the deletion site, GBD 
can bind to the UASG and be recruited to the region. When GBD-TD fusion proteins are 
bound to UASg, they recruit Sir4p, and silencing of the downstream marker is reestablished 
(Xie et al. 2001). We substituted each serine of TD in the GBD fusions by either threonine 
or glutamatic acid. For controls, we also replaced the serines with cysteines (C), which mimic 
the structure of serines but cannot be phosphorylated, or with glutamines (Q), which are 
similar to glutamate but without the negative charges. Whereas the wild-type TD established 
silencing 5-10 times more effectively than the control (GBD only) and the original TD mutant 
(S1094L), the T and E substitutions enhanced silencing 2-10 fold (Figure 2). The E 
substitutions of the second serine (1095) worked as well as the wild type. However the C 
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and Q substitutions did not affect silencing by our assay (Figure 3). These results strongly 
suggest that TD is modified by a kinase(s) and that the modification is responsible for its 
biological activity. The data also indicate that both of the serines could be phosphorylated, 
although we can not conclude that both phosphorylations are necessary for TD function. 
The addition of negative charges to TD by phosphorylation helped us explain an early 
observation that GBD-TD could automatically activate a downstream marker gene located 
outside of HMR (Gai and Voytas, unpublished data). It has been reported that a highly 
negatively charged domain could be used as a transcriptional activator (Ma and Ptashne 
1987). 
We were curious about the two conserved amino acids of TD other than the serines. They 
may be conserved for two possible reasons (or both): they may be needed for the TD and 
Sir4p interaction; they may be conserved for kinase recognition. If the second reason is true, 
after the phosphorylation has been mimicked by an E substitution, the amino acid sequence 
of the other conserved residues should not matter any more. In the tethered silencing assay, 
we tested the S1095E mutation in combination with previously identified mutations at 
LI092, S1094 and P1097. No mutants were able to establish silencing (data not shown). 
This suggests that L and P are needed for the TD/Sir4p interaction, or they are needed for a 
kinase to recognize and phosphorylate the other serine (SI094). 
In addition to the tethered silencing assay, we tested the new TD mutants for their ability to 
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break telomeric silencing. These mutants were different from the wild type and they could 
not break silencing like the wild type TD (data not shown). Our lab has shown that loss of 
telomeric silencing is due to the degradation of Sir4p that results from the interaction between 
TD and Sir4p. The TD/Sir4C interaction is necessary but not sufficient for Sir4p turnover 
(Tuerst and Voytas, unpublished). Intact GBD function (binding to its DNA sequence) is 
also needed for the effect. Furthermore, the C-terminus of Ty5 integrase that includes TD 
and which has a stronger effect on tethered silencing, also fails to break telomeric silencing 
(Xie and Voytas, unpublished). Therefore, the telomeric silencing test is possibly not simply 
a measure of the TD/Sir4p interaction. 
We also used the two-hybrid assay to measure the ability of the T and E substituted TDs to 
interact with Sir4C. These mutants showed the weakened interaction with Sir4C compared 
to the wild type TD, however the interaction is stronger compared to the original mutant 
(S1094L) and the negative control (data not shown). 
We identified the original TD mutants using our plasmid-based targeting assay (Gai and 
Voytas 1998). In this assay, a plasmid containing HMR is used to attract Ty5 insertions. 
When Ty5 cDNA transposes, it could insert either into the genome or into the plasmid. On 
suitable growth media, a genomic insertion would give rise to a red or red sectored colony, and 
a plasmid insertion would give a white colony. The percentage of white colonies is a 
quantitative measure of Ty5 targeting. The wildtype Ty5 has approximately of 8-10% white 
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colonies, and the TD mutants have 0.5 to 3% white colonies (Xie et al. 2001). 
To examine the effect of the E mutations on Ty5 targeting, three Ty5 mutants - two with a 
single E substitution and one with the double E substitution - were constructed and tested in 
the targeting assay. The results are listed in Table 1. Consistent with the tethered silencing 
assay, the S1095E mutation has no effect on Ty5 targeting, and the S1094E mutation showed 
a moderate decrease (from ~8% to ~5%). The double mutation has more severe effect on 
targeting (-3%). This data could be explained in either of two ways: It is possible that 
double phosphorylation of the serines is not good for Ty5 targeting; alternatively, the E 
mutation may not exactly mimic phosphorylation. In the latter situation, when one serine is 
substituted with E, the other one still undergoes modification. We favor the second 
explanation since the double E mutant retains some degree of targeting (i.e. it is better than 
any originally characterized targeting mutants (Xie et al. 2001). 
Kinases modify the targeting domain. 
To identify the kinases that modify Ty5 TD, a yeast deletion collection was screened 
(Research Genetics Inc.). There are 135 possible kinases in the yeast genome (Hunter et al. 
2000), of which 109 kinase knockout strains are available . The knockout strains are in a 
BY4742 background (MAT_ his3_l leu2_0 lys2_0 ura3 _0 ). We decided to use the 
targeting assay for the screen, so we had to reconstruct the knockout strains to make them 
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suitable for the assay. Strain YDV578 was derived from YPH499 (MATa ura3-52 lys2-801 
ade2-101trpl-A63 his3-A200 Ieu2-Al) by knocking out RAD52 with a LEU2 marker. We 
mated this strain with the kinase knockout strains and sporulated the diploids. Offspring 
with the genotype Karf Leu+ trpl ade2 (ura3 his3) were selected. Their mating types were 
determined by mating with test strains; this also ensured that the strains were haploid. We 
found that five kinase knockout strains, 121E10 (Aste20), 125F7 (Afus3), 131B9 (Apkh2), 
139A8 (Aste7) and 149G7 (Astell), were unmatable. We also did not get diploids from strain 
143E10 (Actkl), due to its slow-growth and cold-sensitive phenotype. There were two 
strains, 123G5 (Apho85) and 147G3 (Aspsl), that could not be sporulated, and four strains, 
133H6 (Abckl), 143C1 (Adbf2), 171C10 (Avpsl5) and 171D4 (Abud32), for which haploid 
offspring could not be identified. Hence, 97 new strains were constructed. Then the target 
plasmid (pXW72 with the HMR locus and marker genes TRP1 and ADE2, Gai & Voytas, 
unpublished) and the Ty5 plasmid (pNK254 with a URA3 marker (Zou et al. 1996)) were 
transformed to the strains. After induction of Ty5 expression, the transposition events were 
selected on His- media, and the percentage of white colonies was determined. 
To make a control strain, wildtype BY4742 was mated to YDV578 and reconstructed as 
described above. The targeting assay was performed with both mating type a and _ control 
strains, which gave the expected 7-8% white colonies (Table 2). We found that there were 28 
constructed kinase knockout (CKK) strains with significant changes in the assay, that is, less 
than 5% white colonies. Multiple (at least two, but mostly three) transformants were tested 
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for each of these strains. In most cases, the results were consistent among the parallel tests. 
However, there were a few strains with variable results, which may be due to some colonies 
losing the target plasmid more slowly, and hence being counted as white colonies. Another 
possibility is that regulation by the kinase is leaky. Among the 28 CKK strains, there were 
three strains, 101E6 (Akin3), 103A11 (Ayml059c), and 117B8 (Ahsll), with percentages of 
white colonies less than 2%, and three other strains, 114F11 (Ayckl), 129D8 (Aprkl), and 
145B9 (Afabl), with percentages between 2% and 3% (Table 2). These numbers were close 
to the number of white colonies observed for the elements with TD mutations (less than 3%). 
It is unlikely that all the kinases identified are involved in modifying the Ty5 TD. We 
therefore further characterized the six mutants with the extreme phenotype by testing in vitro 
binding between TD and Sir4C. The experiments were performed as described above, except 
that GBD-TD was expressed and purified from the different kinase knockout strains 
(BY4742 background). We expected that the GBD-TD and Sir4C binding would be 
significantly decreased, according to the targeting assay data, but the results showed no 
obvious differences. We also tested targeting with the Ty5 S1095E mutant. The rationale for 
this experiment was that the mutation should bypass the requirement for phosphorylation, 
and so targeting of this element should not be affected in the kinase mutants. However, this 
was not the case (Table 2). Both sets of data, therefore, suggested that these kinase 
mutations affect the targeting assay rather than Ty5 targeting itself. This conclusion was 
confirmed for strain 101E6 (Akin3). We sequenced eight Ty5 insertions in the AA:m3strain to 
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find out where they inserted in the genome. They were all targeted: five of them were located 
in telomeric regions and three in the HM loci (data not shown). 
To find out the kinases involved in Ty5 targeting, a second screen was performed with the 28 
CKK strains. As described above, we inferred that the E mutations should restore the 
targeting phenotype if a kinase mutant is really involved in the phosphorylation of the 
corresponding serine. Unfortunately, the S1094E mutation is not quite useful for such 
experiments, since it targets at 5%, which is too close to most of the kinase knockout 
phenotypes (3-5%). Only the other E substitution (S1095E) is suitable for the screen; it 
targets at 8%. Eight CKK strains, 110G12 (Akinl), 115F2 (Asat4), 117F6 (AtpkS), 119D2 
(Amkkl), 124A9 (Airsl). 136F12 (Aprr2), 137D4 (Achkl) and 138F2 (Adunl). are restored 
by the Ty5 mutation with percentages of white colonies averaging 6-12% (Table 2). Two 
strains 124A9 (Airsl) and 138F2 (Adunl) had consistent results in at least three individual 
tests, but the others had variations with percentages less than 7% or greater than 10%. All of 
these kinases are possible candidates for being directly or indirectly involved in the S1095 
modification. 
Confirming the kinase mutants 
As mentioned above, the interaction between TD and Sir4p was observed in three in vivo 
experiments: tethered silencing at HMR, loss of telomeric silencing and two-hybrid assays. 
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We tested eight kinase mutants for how they affected each of these in vivo assays. To 
knockout the eight kinases in the appropriate test strains, primers matching the flanking 
regions of the kinases were designed to amplify the fragments of the original Kanr knockout 
cassettes. The PCR products were then transformed into the strains and the Kanr marker 
was used to select the knockouts, which were then confirmed by another round of PCR. 
One group of the kinases appears to be regulators of silencing (Figure 4A). Surprisingly, we 
observed a derepression in telomeric silencing in three strains, Atpk3, Amkkl and Aprr2. 
However, the results were independent of the targeting domain. Further work showed that 
Mkklp strengthens silencing at telomeres, mating loci and the rDNA, and the others work 
only on telomeres (Dai and Voytas, unpublished). The Ty5 targeting alternation in these 
mutant strains possibly relates to the weakening of silencing. Nevertheless, these kinases 
may be involved in TD modification, because their mutations can be restored by the E 
substitution, and they have a slightly changed interaction in two-hybrid assays (Figure 4B). 
The second group of kinases includes Irslp and Kinlp. Loss of these proteins increased the 
tethered silencing and two-hybrid interactions (Figure 4B, C). This suggests that they play a 
role in TD modification. However, there is not a direct explanation to connect these results 
with the targeting assay results. 
The third group of kinase knockouts had the results expected for a reduction in TD 
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phosphorlyation. Dunlp, the DNA damage checkpoint kinase (Hunter et al. 2000), is 
required for TD to break telomeric silencing and to interact with Sir4C in the two-hybrid 
assays (Figure 4A, B). However, it has no obvious effect on tethered silencing (Figure 4C). 
This conflicting result may be explained by the fact that the tethered silencing is less sensitive 
or possibly Dunlp confers leaky regulation. To confirm the role of Dunlp in breaking 
telomeric silencing, an episomal copy of the gene was introduced to the knockout strain, and 
the phenotype was successfully restored (Data not shown). Another checkpoint kinase 
Chklp (Liu et al. 2000) and the kinase Sat4p have similar but less observable effects in the 
two-hybrid assays (Figure 4B). 
Discussion 
The targeting domain is phosphorylated in vivo. 
Ty5 encodes a short domain that guides integration site choice. When separated from 
integrase, this targeting domain (TD) interacts with Sir4p in vivo and in vitro. Several lines of 
evidence suggest that TD is phosphorylated and that phosphorylation is required for 
interaction with Sir4C in vivo and in vitro. First, the in vitro interaction between TD and 
Sir4C requires that TD is expressed in yeast cells. Second, TD binding to Sir4C is disrupted 
by treatment with a protein phosphatase. Finally, TD retains partial function when critical 
serines are replaced with threonines or glutamates. The Sir4p domain that interacts with TD 
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has also been characterized in our lab, and is comprised of two leucines, two tryptophans and 
one arginine residue (Fuerst, Zhu and Voytas, unpublished). Since positive residues often 
interact with negative residues, this Sir4p domain may directly interact with the 
phosphorylated form of TD. 
Because two serines are involved, there are four possible modified forms of TD: forms with 
none, both or either one of the serines modified. Although our results suggest 
phosphorylation is critical for in vitro binding, we do not know which serine is modified. 
The substitution mutants suggest that either serine could be phosphorylated. We favor the 
hypothesis that both serines are modified for the following reasons: A) the targeting assay 
results showed that the two serine mutants have equal effects (Xie et al. 2001). This 
indicates that they play equivalent roles. B) the double E substitution mutant of Ty5 was 
still partially targeted (3% in the targeting assay), and this was significantly different from the 
serine mutants (0.5-1%) (Xie et al. 2001). If only one serine is phosphorylated, we expected 
the double mutant to target as efficiently as one of the serine mutants. 
There are four kinds of experiments to demonstrate the interaction between TD and Sir4p. In 
the tethered silencing and loss of silencing assays, the binding partner of TD is the full-length 
Sir4p; in the other experiments, it is the Sir4p C-terminus (950-1358). Loss of silencing is 
not directly due to the TD/Sir4p interaction. Rather, the decrease in silencing is caused by 
the degradation of Sir4p, which depends on 1) the presence and accumulation of GBD-TD, 2) 
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the DNA binding ability of GBD, and 3) Rislp and other Sir proteins (Fuerst and Voytas, 
submitted). The differences in the assays should be taken into account when considering 
inconsistencies in the behavior of the substitution mutants among different experiments. The 
threonine and glutamate substitutions did not disrupt telomeric silencing, although they 
tethered silencing to a level comparable to the wild type TD. This suggests that the 
phosphorylated serines are essential for Sir4p turnover. In tethered silencing and Ty5 
targeting, the S1095E mutant functioned better than the S1094E mutant, and did as well as 
the wild type. However, the S1095E mutation weakened the ability to bind Sir4C in two-
hybrid and in in vitro binding assays (Xie and Voytas, data not shown). This may be due to 
the different versions of Sir4p involved in the interaction (full-length Sir4p vs. Sir4C). It may 
be because the serine phosphorylation is different from the glutamate so that the wildtype 
TD interacts better with both forms of Sir4p. Alternatively, we assume that different forms 
of modified TD coexist and interact with Sir4p. Since the different length of Sir4p may have 
a slightly varied structure at the binding site, the assumption may raise a possibility of a 
dynamic interaction. That is, Sir4p may bind to a form of TD first, then TD switches to 
another modified form, which consequently changes the binding to Sir4p and forces Sir4p to 
shift its structure. The structural change may then trigger the turnover of Sir4p. This 
hypothesis is attractive, since it connects the observation of TD-induced Sir4p degradation 
with an explanation of the accessibility Ty5 needed for integration to silent chromatin. 
Unfortunately, we do not have any evidence for this model yet. 
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Kinases regulate Ty5 targeting. 
We applied our targeting assay to identify the kinases that directly or indirectly modify 
TD. The assay quantitatively measures the proportion of Ty5 integration events that 
occur into an episomal HMR locus. We expected that kinase mutations that affect 
silencing would cause false results. However, there is no report of kinases that affect 
silencing, except for mutations in MEK1, which is an essential gene and is not included in 
the collection. Surprisingly, 28 kinases out of the 97 tested (~ one third) significantly 
altered the results of the targeting assay. We went through a second screen, taking 
advantage of the S1095E mutant, which has the phosphorylation mimicked by a 
negatively charged amino acid, and which has wild type target specificity. Thus, the 
S1095E mutation should suppress the mutant phenotype of kinases that modify TD. 
Eight candidate kinases were found, among which three regulate silencing, and the others 
have varied effects on the TD/Sir4p in vivo interaction. Among the latter class, Dunlp 
is the best candidate for the kinase that modify s S1095; dunl mutations significantly 
decrease the ability of GBD-TD to break silencing, and they abrogate the TD/Sir4C two 
hybrid interaction. However, we believe that Dunlp has a redundant activity and/or 
indirectly modifies TD. This conclusion is based on the observation that dunl mutants 
only reduce Ty5 targeting moderately (to ~5%) and in the dunl knock out strain, TD is 
still able to establish silencing when tethered to a crippled HMR locus. Further 
experiments are needed to determine whether and how the candidate kinases modify TD 
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and affect targeting. 
Irslp is another strong candidate kinase based on the targeting assay data. Interestingly, 
irsl mutations increased rather than decrease the interaction between TD and Sir4p, as 
shown by the tethered silencing and two-hybrid assays. To explain this, we consider 
the hypothesis of dynamic binding mentioned above. We think that the lack of a 
specific kinase may limit the TD modification to one form, which in this case, favors its 
function in tethered silencing and two-hybrid assays, but prevents its transition to a 
second form involved in targeting. 
Many kinases are employed to respond to stimulation from the internal and external 
environment. Three of the eight candidate kinases are involved in stress response — sat4 
strains are sensitive to 1M NaCl (Mulet et al. 1999), Irslp is involved in the protein kinase C 
pathway (Miyahara et al. 1998), and mkkl strains are sensitive to glycerol and nitrogen 
starvation (Irie et al. 1993). DUN1 and CHK1 are checkpoint genes, and Tpk3p (Garrett and 
Broach 1989) is a subunit of the cAMP-dependent protein kinase complex. These latter 
genes are crucial to respond to intracellular signals. The functions of these kinases imply that 
Ty5 integration is regulated by the environment. It is possible that in certain circumstances, 
Ty5 residing in silent chromatin will be expressed by derepression, as suggested by the mkkl, 
tpk2 andprr2 mutant, then the progeny elements will integrate randomly. This will result in 
the "explosion" (sudden and notable multiplication) of the element and cause dramatic change 
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to the host genome. Therefore, the evolution of the organism will be speeded up to fit a new 
environment. 
Materials and Methods 
Plasmids and Strains 
See Table 3. 
In vitro Binding and In vivo Assays 
The assays to demonstrate the interaction between Ty TD and Sir4p are described in our 
previous paper (Xie et al. 2001). To treat the immuno-precipitated GBD fusion proteins 
with XPPase, the final wash was performed with 1 X XPPase buffer instead of 1 X PBS. The 
beads were incubated at 30°C with 0.5|il (200 units) enzyme for 25 minutes before mixing 
with the labeled Sir4C. 
Targeting Assay 
The targeting assay was described previously (Gai and Voytas 1998). Here we used the 
target plasmid pXW72 with a TRP1 marker (Gai, unpublished) rather than pXW78 with a 
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LEU2 marker. 
Constructing the Kinase Knockout Strains 
To construct YDV578, the RAD52 knockout plasmid pSM20 was digested by BamWl and 
directly transformed to strain YPH499. The transformants were selected on SC-L plates and 
confirmed by PGR. 
YDV578 and the kinase knockout strains (in the BY4742 background) were grown on YPD 
plates overnight. Both types of strains were mated on YPD plates at 30°C for 4-6 hrs. 
Diploids were selected on SC-Leu-Trp plates and grown in liquid selective media overnight 
(to O.D.600 less than 3). 1 ml of the cells was collected and washed once, then transferred to 
1 ml of sporulation medium. The cultures were incubated at 30°C for 3 overnights with 
vigorous shaking. The cells were diluted 5 times, and 1 ml was transferred to new tubes. The 
cells were spun down and washed once. 100 |il of 0.5mg/ml zymolyase (in 1M sorbitol or 
water) was added to each tube followed by 30°C incubation overnight. The cells were 
collected, washed twice, and suspended in 1 ml of water. The cells were then diluted 100 
times and plated (10 jxl- 100 (0.1) to SC-Leu+G418+5FAA medium (Toyn et al. 2000). 
After 4-5 days of growth (first 3 days at 30°C, then at RT), a few colonies turned red. Three 
to five (or more) colonies were picked for each strain and made into small patches or struck 
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out on SC-Leu+G418 plates. The plates were replicated to SC-Trp-Leu (+G418) to make 
sure they were Trp-. The colonies were also mated to the mating type test strains (YDV515 
and YDV516) to determine the mating types and confirm that they were haploids. 
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Table 1. Targeting assay results of Ty5 mutants. 
Ty5 mutants Percentage in Sequence 
targeting assay of TD 
pNK254(WT) 7.8% LDSSPP 
pWW79 7.7% LDSEPP 
rut38* 1.1% LDSLPP 
rut46* 0.6% LDSEPP 
pWW102 5.0% LDESPP 
pXW137 0.5% LDLSPP 
rut41* 0.7% LDESPP 
PWW103 3.7% LDEEPP 
* Data from our previous paper (Xie et al., 2000) 
Table 2. Selected targeting assay results in the strains of kinase knockout. 
Strains /pNK254 with wildl ype Ty5* /pWW79 with S109 52 Ty5* 
4742a# 71/980 57/720 46/588 7.6% 8/90 6/94 7.6% 
4742a# 31/421 43/417 1 9/304 8.1% 18/255 24/317 17/193 7.7% 
101E6 1/208 2/403 0.5% 3/343 0/145 2/248 0.7% 
103A11 3/252 1/295 3/364 0.8% 4/288 2/223 1.2% 
114F11 20/777 17/662 34/1244 2.6% 13/476 2.7% 
117B8 3/154 1/116 2/80 2/141 1.6% 3/60 1/81 1/82 2.2% 
129D8 6/233 2/92 3/115 2.5% 3/99 2/53 1/49 3.0% 
145B9 33/1174 16/692 26/906 2.7% 11/361 8/218 4/191 3.0% 
110G12 13/339 13/399 9/360 3.2% 3/151 12/168 18/244 8/137 6/115 5.8% 
115F2 9/262 7/232 7/245 3.1% 5/115 10/120 6/70 35/479 6/61 7.3% 
117F6 38/1059 12/564 26/686 3.3% 18/289 25/365 13/303 5.9% 
119D2 33/685 30/793 10/341 4.0% 25/314 28/458 19/353 12/150 4/196 6.1% 
124A9 25/924 44/1254 31/731 3.4% 100/1311 49/684 42/417 7.9% 
136F12 30/772 26/838 52/1091 4.0% 75/745 26/209 68/466 11.9% 
13704 37/899 50/1091 41/1081 4.2% 36/531 70/784 11/226 7.6% 
138F2 38/782 44/911 56/1101 4.9% 17/233 13/154 32/349 8.4% 
# These strains are reconstructed by crossing of BY4742 and YDV578. The mating types were marked by a and a. 
* The numbers indicate "the number of white colonies/total colonies" from individual plates. The percentages were 
calculated by "the sum of white colonies" divided by "the sum of the totals". 
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Table 3. Plasmids, strains, and oligos. 
Plasmids 
name vector/insertion reference 
pXW205 pGBDU-C3/TD Xie, et al. 2000 
pXW213 pGBDU-C3/td(S1094L) Xie, et al. 2000 
pWW54 pGEX-4T1/TD Xie, et al. 2000 
pWW55 pGEX-4T1/td(S1094L) Xie, et al. 2000 
pWW56 pCITE-2a(+)/Sir4C Xie, et al. 2000 
pWW73 pGBDU-C3/td(S1094T) This study 
pWW74 pGBDU-C3/td(S1095T) This study 
pWW75 pGBDU-C3/td(S1094E) This study 
pWW76 pGBDU-C3/td(S1095E) This study 
pWW79 pNK254(S1095E) Zuo et al. 1997; This study 
pWW82 pGBD-C3/td(S1094T) This study 
pWW83 pGBD-C3/td(S1095T) This study 
pWW84 pGBD-C3/td(S1094E) This study 
pWW85 pGBD-C3/td(S1095E) This study 
pWW86 pGBDU-C3/td(L1094V, S1095E) This study 
pWW87 pGBDU-C3/td(S1094L, S1095E) This study 
pWW88 pGBDU-C3/td(S1095E, P1097Q) This study 
pWW89 pGBDU-C3/td(S1094E, S1095E) This study 
pWW102 pNK254(S1094E) Zuo et al. 1997; This study 
pWW103 pNK254(S1094E, S1095E) Zuo et al. 1997; This study 
pJB82 pRS414/Dun1 ORF+1 kb flanking This study 
pSM20 pBR322/rad52::LEU2 L. Prakash and S. Prakash, 
University of Texas, Galveston) 
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Table 3. (continued) 
Strains 
strain genotype reference 
W303-1B MATa ade2-1 ura3-1 his3-11,15 Ieu2- R. Rothstein 
3,112 trp1-1 can1-1 
YSB2 W303-1B aeB::3xUASa hmr::TRP1 Chien et al. 1993 
gal4::LEU1 
UCC3505 MATa ade2-101 his3-A200 Ieu2-A1 Iys2- Singer and Gottschling, 
801 trp1-A63 ura3-52 ppr1::HIS3 1994 
adh4::URA3-TEL-VIIL DIA5-1 
BY4742 MATa his3A1 leu2A0 lys2A0 ura3A0 From Research Genetics 
YNK313 YPH499 rad52::TRP1 Gai and Voytas, 1998 
YPH499 MATa ura3-52 Iys2-801 ade2-101 trpl- From Stratagene 
A63 his3-A200 Ieu2-Al 
YDV578 YPH499 rad52::LEU2 This study 
YDV515 MATa thr4~ Chapter 13 Current 
Protocols in Molecular 
Biology 
YDV516 MATa thr4~ Chapter 13 Current 
Protocols in Molecular 
Biology 
L40 MATa his3-A200 trp1-901 Ieu2-3,112 gift from Rolf Sternglanz 
ade2 lys2-801 amL YS2::(lexAop)4-HIS3 
URA3::(lexAop)8-lacZ-GAL4 ga!4 ga!80 
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Table 3. (continued) 
Oligos 
oligo sequence (5' to 3') application 
DV0690 AATTCTTGGATTCATCGCCTCCAAATACC insert TD to pGBD vectors 
TCA 
DV0691 GATCTGAGGTATTTGGAGGCGATGAATCC insert TD to pGBD vectors 
AAG 
DV0752 AATTCTTGG ATTtAT CGCCT CCAAATACCT insert td (S1094L) to pGBD 
CA vectors 
DV0753 GATCTGAGGTATTTGGAGGCGATaAATCC insert td (S1094L) to pGBD 
AAG vectors 
DV01443 AATTCTTGGATaCATCGCCTCCAAATACC insert td (S1094T) to pGBD 
TCA vectors 
DV01444 GATCTGAGGTATTTGGAGGCGATGtATCCA insert td (S1094T) to pGBD 
AG vectors 
DV01445 AATT CTT GG ATTC AaCGCCT CCAAATACC insert td (S1095T) to pGBD 
TCA vectors 
DV01446 GATCTGAGGTATTTGGAGGCGtTGAATCCA insert td (S1095T) to pGBD 
AG vectors 
DV01447 AATT CTTGG ATgaAT CGCCT CCAAATACC insert td (S1094E) to pGBD 
TCA vectors 
DV01448 GATCTGAGGTATTTGGAGGCGATtcATCCA insert td (S1094E) to pGBD 
AG vectors 
DV01449 AATTCTTGGATTCAgaGCCTCCAAATACC insert td (S1095E) to pGBD 
TCA vectors 
DV01450 GATCTGAGGTATTTGGAGGCtcTGAATCCA insert td (S1095E) to pGBD 
AG vectors 
DV01514 AATT CgTGG ATT CAgaGCCT CCAAATACC insert td (L1092V, S1095E) to 
TCA pGBD vectors 
DV01515 GATCTGAGGTATTTGGAGGCtcTGAATCCA insert td (L1092V, S1095E) to 
cG pGBD vectors 
DV01516 AATTCTTGGATTtAgaGCCTCCAAATACCT insert td (S1094L, S1095E) to 
CA pGBD vectors 
DV01517 GATCTGAGGTATTTGGAGGCtcTaAATCCA insert td (S1094L, S1095E) to 
AG pGBD vectors 
DV01518 AATTCTTGGATTCAgaGCCTCaAAATACC insert td (S1095E, P1097Q) to 
TCA pGBD vectors 
DV01519 GATCTGAGGTATTTtGAGGCtcTGAATCCA insert td (S1095E, P1097Q) to 
AG pGBD vectors 
DV01520 AATT CTT G G AT ga AgaG CCT CCAAATACC insert td (S1094E, S1095E) to 
TCA pGBD vectors 
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Table 3. (continued) 
oligo sequence (5' to 3') application 
DV01521 G ATCT G AGGTATTTGG AGGCtcTtcAT CCA 
AG 
CATCGTT GG ATTCAgaGCCTCCAAATACC 
GGTATTTGGAGGCtcTGAATCCAACGATG 
CATCGTTGGATgaATCGCCTCCAAATACC 
DV02110 ATTTGGAGGCGATtcATCCAACGATGGAGG 
DV02111 TCGTTGGATgaAgaGCCTCCAAATACCTCA 
ATTTGGAGGCtcTtcATCCAACGATGGAGG 
ATCTCCAAGAGAGTTGGG 
GCCTCAGCAGGTGCGGCC 
GAATAGAAGCCCCTGAATACC 
CAATGCCAAAGGTGCGCTGG 
GTGCTGGAGAAATCAGAGGC 
gggaattcG AAGCCCCT GAAT ACC 
ggggatccttagaggcaagataattc 
DV02457 TTTGCGCTACTTCGCTGTCC 
DV02458 AATCCTCAATGGGTGGCAAAC 
ATCGAGCTCTCCCATGATGC 
CTCGGTGCTGCCGGATTG 
GGCACGCCGTCAGGCAG 
ATTT G AATTATAGGAACGCCAAG 
GCCACTGGTCATCCCGTGC 
DV02464 GGGTTCACACCGGGCGAC 
DV02465 ACCAAATACTATGTTCCGCTAAAG 
DV02466 ATACCGTACACCTGCTGGCG 
CTCATGGGAGTTACGTTTGC 
GTGTGATGAAAGTGCGCGCC 
DV02469 ACGATTTCCTGTCGGTTTCG 
DV02470 CGATAATAACCGCGGGCATG 
DV02471 TAACAGGCCGAGCTCTTGCC 
DV02472 TCCGTTGCTTCAGCTACGGG 
DV02473 TATCCTGTTTTCCCTGGGTG 
CCTCATTATGCAGTTTCCGG 
AACAAG AAATTATGGCGTT GAGG 
DV02476 TGTCCTGGTAAACGGTGCAATG 
DV02477 CCAACGCGGCGCCAATG 
DV02010 CTGCAGCGAGGAGCCGTAAT 
DV01487 
DV01488 
DV02109 
DV02112 
DV0392 
DV0393 
DV02454 
DV02455 
DV02456 
DV02521 
DV02522 
DV02459 
DV02460 
DV02461 
DV02462 
DV02463 
DV02467 
DV02468 
DV02474 
DV02475 
insert td (S1094E, S1095E) to 
pGBD vectors 
mutate Ty5 S1095E 
mutate Ty5 S1095E 
mutate Ty5 S1094E 
mutate Ty5 S1094E 
mutate Ty5 S1094E, S1095E 
mutate Ty5 S1094E, S1095E 
confirm rad52::LEU2 knockout 
confirm rad52::LEU2 knockout 
Knockout dun1/YDL101 C::KanR 
knockout dun1/YDL101C::KanR 
confirm dun1/YDL101C::KanR 
clone DUN1 to pJB82 
clone DUN1 to pJB82 
knockout isr1/YPR106W::KanR 
knockout isr1/YPR106W::KanR 
confirm isr1/YPR106W::KanR 
knockout prr2/YDL214C::KanR 
knockout prr2/YDL214C::KanR 
confirm prr2/YDL214C::KanR 
knockout chk1/YBR274W::KanR 
knockout chk1/YBR274W::KanR 
confirm chk1/YBR274W::KanR 
knockout mkk1/YOR231 W::KanR 
knockout mkk1/YOR231 W::KanR 
confirm mkk1/YOR231 W::KanR 
knockout sat4/YCR008W::KanR 
knockout sat4/YCR008W::KanR 
confirm sat4/YCR008W::KanR 
knockout tpk3/YKL166C::KanR 
knockout tpk3/YKL166C::KanR 
confirm tpk3/YKL166C::KanR 
knockout kin1/YDR122W::KanR 
knockout kin1/YDR122W::KanR 
confirm kin1/YDR122W::KanR 
kanB for comfirming all the 
KanMX4 knockouts 
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GST TD td GBD TD td 
PPase -
TD td 
+ 
TD 
Figure 1. In vitro binding of TD and Sir4C suggest that TD is phosphorylated. 
Sir4C is expressed and 35S labeled by a transcription/translation kit. TD and its 
mutant (td) were either fused to GST, expressed and purified form E.coli cells (left 
3 lanes), or fused to GBD, expressed and immuno-purified from yeast cells 
(middle and right). TD lost its binding to Sir4C when it was expressed in E. Coli 
(the 2nd lane) or after XPPase treatment (last lane). 
110 
Plasmid TD sequence 
G?" 
pGBDUCI no TD 
pXW205 LDSSPP 
pXW21 3 LDLSPP 
pWW73 LDISPP 
pWW74 LDSIPP 
pWW75 LDESPP 
pWW76 LDSEPP 
SC-Ura SC-Ura-Trp 
Figure 2. The TD mutants with threonine or glutamate substitutions at either of the 
serines could be functional in reestablishing silencing at the crippled HMR locus 
in the strain YSB2. The cell cutures were grown to saturation and diluted to O. 0. 
0.5. Then, 5-fold series of dilution was made and 10 jxl of each dilution was 
spotted onto the control (SC-Ura) and test (SC-Ura-Trp) plates. 
I l l  
Plasmid TD sequence 
pGBDUCS no TD 
pXW205 LDSSPP 
pXW21 3 LDLSPP 
pWW11 3 LDCSPP 
pWW114 LDSCPP 
pWW11 5 LDQSPP 
pWWI 1 6 LDSQPP 
SC-Ura SC-Ura-T rp 
Figure 3. The TD mutants with cysteine (C) or glutamine (Q) substitutions at either 
of the serines could not be functional in reestablishing silencing at the crippled 
HMR locus in the strain YSB2. The cell cutures were grown to saturation and 
diluted to O. D. 1. Then, 10-fold series of dilution was made and 10^1 of each 
dilution was spotted onto the control (SC-Ura) and test (SC-Ura-Trp) plates. 
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UCC3505 
WT 
Adunl 
Airs! 
Aprrl 
Achkl 
Amkkl 
Asat4 
Atpkl 
Akinl 
GBD-TD GBD-td 
SC-Trp SC-Ura-Trp SC-Trp SC-Ura-Trp 
Adunl 
Achkl 
Asat4 
SC-Leu-Ura-Trp SC-Leu-Ura-Trp-His SC-Leu-Ura-Trp-His 
+1 mM 3AT +5mM 3AT 
GBD-TD 
GBD-td 
Adunl 
Amkkl 
SC-Ura SC-Ura-Trp 
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CHAPTER IV. CONCLUSIONS 
At the end of 1997, before I decided to join the Voytas laboratory to study the 
retrotransposon Ty5, a functional Ty5 element was found in Saccharomyces paradoxus, a 
relative of S. cerevisiae. The target specificity of this Ty5 element was well characterized; 
over 90% of native and de novo Ty5 insertions were found within silent chromatin. The 
integrity of silent chromatin was also demonstrated to be necessary for Ty5 targeting. When 
the transcriptional silencer at the HMR locus was impaired and hence silencing was 
defective, the frequency of Ty5 insertion to the non-silenced HMR locus was decreased. 
Mutations in genes encoding essential components of silent chromatin, such as SIR2, SIR3, 
and SIR4, caused global changes in Ty5 integration site choice. These data suggested a 
simple working model for the mechanism of targeting: the pre-integration complex (PIC) of 
Ty5 interacts with some feature of silent chromatin to guide integration. 
At the time I joined the lab, a plasmid-based targeting assay was developed and used to 
screen mutagenized Ty5 elements to identify element-encoded targeting determinants. A 
missense mutation near the IN and RT border was found to cause a targeting defect. I 
continued this work and started by asking a simple question: could I found more of this kind 
of mutation? After more than five years of investigation, I describe in this thesis the 
information I gathered. In this section I summarize my findings, discuss related 
observations, and, more importantly, describe the questions that still puzzle me. 
115 
The Ty5 targeting domain is defined 
The answer to my original question was yes: I could find more targeting mutants. Eleven 
additional point mutations were identified that dramatically changed Ty5 target specificity. 
All the mutations, including the original, occur at one of four amino acid residues that 
together span on a six amino acid stretch (LDSSPP, the four critical residues are underlined). 
We called this motif the targeting domain (TD). The other amino acid residues around and 
within the domain were also mutated, and it was found that they do not contribute to target 
specificity. 
The targeting mutants decreased transposition efficiency 
The mutants we found in our screen not only changed targeting, but they also reduced 
transposition efficiency. The more severe the targeting defect, the lower the transposition 
efficiency (see the chart below). There are two possibilities to explain this phenomenon. 
First, it is possible that integration outside of the preferred target sites is less efficient. In this 
case, TD might facilitate transposition. The second possibility is that the PICs of the mutant 
elements are still recruited to silent chromatin; however, they have less ability to be 
integrated. In the second scenario, it is assumed that silent chromatin provides a barrier for 
element insertion, as was observed for the inability of DNases and restriction endonucleases 
to digest DNA bound by silent chromatin. Therefore, in this second hypothesis, TD possibly 
has a role in opening heterochromatin rather than simply recruiting the PIC. This is 
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supported by the observation in the in vitro binding that the mutant IN C-terminus is able to 
bind Sir4 C-terminus, which suggests TD is redundant for recruiting PIC. 
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TD is encoded by IN not by RT 
Ty5 expresses a polyprotein, and the boundaries that define the individual peptides released 
by protease cleavage (e.g. IN and RT) are not defined. We replaced TD with a 6XHis-tag, 
and then showed in Western blots that the tag was associated with IN and not with RT. 
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The C-terminus of IN is sensitive to mutation 
After mutagenizing the C-terminus of integrase, we noticed that more than 60% of the 
elements lost or had lowered frequencies of transposition. One reason that could account for 
the result: stop codons or frameshift mutations were introduced. However, the methods we 
applied for PGR mutagenesis introduce mostly substitutions of A and T to G and C, thus they 
bias against the introduction of stop codons and frameshift mutations. On average, elements 
had 2-8 mutations. Therefore, it is unlikely that fatal mutations were the only reason for the 
observation that 60% of the elements were transposition defective. The result rather 
suggested that the C-terminus is involved in some important functions for the element other 
than targeting. One example, is nuclear localization and we have shown that the IN nuclear 
localization determinants reside within the C-terminus (Fuerst and Voytas unpublished). We 
also showed that a dozen of the mutants failed to recombine with homologous substrates in 
the genome, suggesting that cDNA was not made. This implies that the C-terminus is 
involved in functions other than integration, and support for this comes from work with other 
Ty elements. 
TD nucleates silencing 
HMR silencing is greatly weakened when two of the three protein binding sequences in the 
HMR-E silencer are deleted. Transcriptional silencing can be restored by tethering Sirlp to 
the defective HMR locus. Tethering TD to the locus also restores silencing, and this depends 
on Sir2p, Sir3p and Sir4p, but not Sirlp. Obviously, the role of Sirlp in silencing can be 
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replaced by TD. Sirlp is proposed to recruit Sir4p to establish silencing. TD was later 
shown to bind to Sir4p. 
Overexpression of GBD-TD fusion disrupts silencing 
Telomeric silencing is decreased when a 2pi plasmid expressing a GBD-TD fusion is present 
in the cells. This effect is due to the GBD-TD caused degradation of Sir4p. Degradation 
depends on the ability of GBD to bind DNA and also requires Rislp, a DNA dependent 
ATPase (Fuerst and Voytas unpublished). Overexpression of Sir3p, but not Sir2p and Sir4p, 
can overcome the GBD-TD-induced transcriptional derepression. In addition, a growth 
defect is observed in the strain in which GBD-TD and Sir3p are overexpressed. 
TD interacts with Sir4p 
The interaction of TD with Sir4C was demonstrated in vivo by two-hybrid assays and in vitro 
by affinity binding experiments. In both cases, the nine amino acid peptide (TD with three 
flanking residues) was able to bind Sir4C. However, a longer version of the IN C-terminus 
enhanced the interaction with Sir4p in two hybrid assays. This IN C-terminal fragment could 
bind to Sir4C in vitro, even if TD was mutated or deleted (Xie and Voytas unpublished). 
This data suggests that another region of IN might also interact with Sir4C. 
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TD is phosphorylated 
Several lines of evidence suggest that the serines in TD are phosphorylated and that this 
modification is essential for TD function. We observed doublets of GBD-TD in Western 
blots, whereas versions of GBD-TD with serine substitutions did not form doublets. In 
addition, GBD-TD expressed and purified from yeast cells (and not E. coli) could bind to 
Sir4C in vitro. More importantly, the binding was sensitive to the lambda protein 
phosphatase. When the serines were replaced by threonine or glutamate, TD function was 
partially maintained. 
Kinases involved in TD modification 
We genetically modified 97 kinase knockout strains so that they could be used in the 
targeting assay to screen for kinases that modify TD. Eight kinase candidates were found 
that affect Ty5 targeting. Among these, Dunlp is the most likely candidate, because in dunl 
strains, GBD-TD cannot break telomeric silencing or interact with Sir4C. However, Dunlp 
may have a redundant activity or indirectly modify TD, because GBD-TD can still establish 
silencing at a crippled HMR locus in a dunl background. It is therefore likely that other 
kinases are involved in modifying TD. 
Some kinases affect the targeting assay but not Ty5 targeting 
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We inferred that a kinase that regulates silencing would affect our targeting assay. However 
only one essential kinase involved in silencing has been reported, and it was not included in 
our strain collection. We found three additional kinases that are important for silencing, but 
a total of 28 kinases significantly affected the results of the targeting assay. We further 
analyzed the effect of the kinase Kin3p. When KIN3 was knocked out, the resulting 
percentage in the assay was less than 1%, similar to the Ty5 TD mutants. However, the 
distribution of Ty5 insertions in the genome was not affected. The reason for how this and 
the other kinases affect the targeting assay remains a mystery. 
The Ty5 targeting model is updated 
Ty5 integration preference is executed by integrase. Integrase has a special targeting domain 
(TD), which binds to Sir4p, a component of silent chromatin. Targeting is regulated by the 
host cell, because TD is not functional until it is modified by a yeast kinase. 
The updated model described above looks simple enough. However, a lot more details need 
to be filled in. How does TD interact with Sir4p? Does a barrier exist for the element to gain 
access to DNA in silent chromatin? If so, how does the element break in? How is TD 
phosphorylated? Is one or both serines modified? What kinases do the job? How do they 
regulate Ty5 targeting, and how are the kinases regulated? These questions and others are 
waiting to be answered. 
